Stockwinners Market Radar for February 08, 2018 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
ALGT | Hot Stocks19:21 EDT Allegiant says January estimated average fuel cost per gallon $2.23
|
ALGT | Hot Stocks19:21 EDT Allegiant Travel reports January traffic up 9.3% - Reports January passengers up 8.7%. Reports January ASMs up 6.1%. Reports January load factor up 2.4 points.
|
OMAB | Hot Stocks19:16 EDT OMA Airports reports January passenger traffic up 4.6% y/y - OMA Airports reports that terminal passenger traffic at its 13 airports increased 4.6% in January 2018, as compared to January 2017. Domestic traffic increased 4.5%, and international traffic increased 4.6%.
|
AMGN | Hot Stocks18:47 EDT Amgen: Results from Phase 3 XGEVA study successfully met primary endpoint - Amgen announced results from the XGEVA Phase 3 '482 study, the largest international multiple myeloma trial for the prevention of skeletal-related events ever conducted, were published in The Lancet Oncology. In this study, XGEVA successfully met the primary endpoint, demonstrating non-inferiority to zoledronic acid in delaying the time to first on-study skeletal-related event in patients with multiple myeloma (HR=0.98, 95 percent CI: 0.85-1.14). The median time to first on-study skeletal-related event was 22.8 months for XGEVA and 24 months for zoledronic acid. Approximately 60 percent of all first skeletal-related events occurred within the first three months, and 81 percent occurred within the first six months. Overall survival, a secondary endpoint of the study, was similar between the XGEVA and zoledronic acid arms, with a hazard ratio of 0.90 (95 percent CI: 0.70-1.16). Progression-free survival, an exploratory endpoint not powered for statistical significance, was 46.1 months (95 percent CI: 34.3 months-not estimable, n=219) for XGEVA and 35.4 months (95 percent CI: 30.2 months-NE, n=260) for zoledronic acid on top of standard of care anti-myeloma therapy.
|
AMTD | Hot Stocks18:20 EDT TD Ameritrade EVP Nally sells 17,243 common shares - In a regulatory filing, TD Ameritrade EVP of institutional services Thomas A. Nally disclosed the sale of 17,243 common shares of the company at a price of $56.13 per share.
|
TMO | Hot Stocks18:19 EDT Thermo Fisher CFO sells 5,000 common shares - In a regulatory filing, Thermo Fisher senior VP and CFO Stephen Williamson disclosed the sale of 5,000 common shares of the company at a price of $209.26 per share.
|
NVDA | Hot Stocks18:14 EDT Nvidia: Cryptocurrency demand led to lower channel inventory for Gaming GPUs - On its Q4 earnings call the company noted the cryptocurrency demand for processors. Nvidia met some of that demand with a dedicated board in its OEM business and some demand was met with its Gaming GPUs. The company explained that they are working diligently to get GPUs "down to the marketplace for the gamers." Nvidia added that the most important thing is that they "catch up"
|
VLRS | Hot Stocks18:09 EDT Volaris reports January traffic up 0.4%, capacity up 5.5% - During January, Volaris increased total capacity, as measured in Available Seat Miles, by 5.5% year over year. Total demand, as measured in Revenue Passenger Miles, in January increased 0.4% year over year, reaching 1.4B. Volaris transported a total of 1.5M passengers during the month, a decrease of 2.1% year over year. In January, Volaris increased domestic and international ASMs by 5.3% and 5.8%, respectively. Network load factor for January was 80.1%.
|
GOL | Hot Stocks17:51 EDT GOL Linhas reports January departures up 3.8% y-o-y - GOL reported the number of seats was up 3.6% in January, resulting in an increase in supply of 4.9%. GOL's load factor was 83.5% in January, 0.3 p.p. up over the same period of 2017, due to a growth in demand of 5.2% in the period. In the domestic market, volume of departures and number of seats increased by 2.8% and 2.5%, respectively over January 2017. In addition, GOL increased its supply by 2.3% in January over the same period the year before, while demand grew by 2.7%. GOL's Load factor was up 0.4 p.p. in comparison to the same month of the previous year, achieving 84.0%. In January 2018, GOL's international market supply and demand rose by 27.5% and 27.9%, respectively, increasing load factor by 0.3 p.p. in relation to the same period of 2017.
|
ACRS | Hot Stocks17:44 EDT Aclaris Therapeutics to present data on ESKATA at AAD - Aclaris Therapeutic announced that data will be presented from two Phase 3 clinical trials for ESKATA for the treatment of raised seborrheic keratoses. For the first time, detailed findings from SEBK-302 and SEBK-303 will be presented to attendees at the 2018 American Academy of Dermatology Annual Meeting taking place February 16-20 in San Diego, California. ESKATA, formerly known as A-101 40% topical solution, is the first and only FDA-approved topical, non-invasive treatment for raised seborrheic keratoses.
|
UIS... | Hot Stocks17:41 EDT On The Fly: After Hours Movers - UP AFTER EARNINGS: Unisys (UIS), up 16.8%... MobileIron (MOBL), up 16.3%... FireEye (FEYE), up 13.1%... Nvidia (NVDA), up 11.3%... Skechers (SKX), up 4.8%... Nuance (NUAN), up 4.2%. DOWN AFTER EARNINGS: Expedia (EXPE), down 18.7%... Zillow (ZG), down 7.3%... Sierra Wireless (SWIR), down 4.9%... Glu Mobile (GLUU), down 2.6%. ALSO LOWER: Woodward (WWD), down 9.7% after it said that it is not in talks with Boeing (BA) over a possible acquisition.
|
SGEN CASC | Hot Stocks17:40 EDT Seattle Genetics commences tender offer for Cascadian Therapeutics - Seattle Genetics (SGEN) announced that its wholly-owned subsidiary, Valley Acquisition Sub, has commenced its previously announced tender offer for all outstanding shares of common stock of Cascadian Therapeutics (CASC) at a price of $10.00 per share net to the seller in cash, without interest, less any applicable withholding taxes. The Offer is being made in connection with the Agreement and Plan of Merger, dated as of January 30, 2018, among Seattle Genetics, Valley Acquisition Sub, and Cascadian Therapeutics. The board of directors of Cascadian Therapeutics has determined that the offer is advisable, fair to and in the best interests of Cascadian Therapeutics and its stockholders and unanimously recommends that the stockholders of Cascadian Therapeutics tender their shares. The Offer is scheduled to expire at midnight, New York City time, on March 9, 2018 (one minute after 11:59 p.m. Eastern Time on March 8, 2018), unless the Offer is extended or earlier terminated in accordance with the rules and regulations of the SEC and the merger agreement governing the Offer and the related transactions.
|
ALLE | Hot Stocks17:30 EDT Allegion raises quarterly dividend by 31% to 21c per share - The dividend is payable on March 29, 2018, to shareholders of record on March 15, 2018.
|
WEB | Hot Stocks17:29 EDT Web.com sees ARPU falling in Q1 similarly to Q4 but rise in subsequent quarters
|
UVV | Hot Stocks17:27 EDT Universal Corporation CFO David Moore to retire; Johan Kroner to succeed - David Moore, Senior Vice President and CFO of Universal Corporation has announced his plans to retire effective August 31. The Board of Directors has named Johan Kroner, currently Senior Vice President, to succeed Moore as CFO as of September 1. Moore has been with Universal since 1978 and has served as CFO since 2008. He began his career in the areas of finance and international operations and became Vice President and Chief Administrative Officer in 2006. Prior to that, Moore was responsible for oversight of the company's administrative offices in Europe from 1999 to 2005.
|
SEP | Hot Stocks17:25 EDT Spectra Energy Partners increases quarterly dividend - Spectra Energy Partners announced that the board of the general partner declared a quarterly cash distribution to unitholders of 73.875c per unit, an increase of 1.25c over the previous level of 72.625c per unit. The cash distribution is payable on February 28 to unitholders of record at the close of business on February 20. This quarterly cash distribution equates to $2.955 per unit on an annual basis.
|
HRS | Hot Stocks17:17 EDT Harris awarded $161M U.S. Navy contract modification - Harris Corp is being awarded $161,049,786 for modification P00002 to a previously awarded firm-fixed-price contract to exercise an option for the procurement of 86 full-rate production lot 15 Integrated Defensive Electronic Countermeasures AN/ALQ-214 A(V)4/5 Onboard Jammer systems for the F/A-18 aircraft. In addition, this option provides for the procurement of eight WRA1 A(V)4 receiver/processors and seven WRA2 A4 modulators. This option exercise is in support of the Navy and the government of Australia.
|
NVDA | Hot Stocks17:16 EDT Nvidia says Q4 Auto down 8% from Q3, cites commoditization
|
LGF.A LGF.B | Hot Stocks17:13 EDT Lionsgate resumes quarterly dividend of 9c per share - The dividend is payable on May 1 to shareholders of record as of March 31.
|
WEB | Hot Stocks17:13 EDT Web.com says 'made great strides' across vertical offerings - Says seeing positive results from launch of new company website, which aligns with corporate strategy and simplifies customer buying experience. Says ended the year with improved product portfolio. Comments taken from Q4 earnings conference call.
|
NVDA | Hot Stocks17:11 EDT Nvidia believes cryptocurrency revenue impact higher in Q4 than Q3 - Comments from Q4 earnings call.
|
EXPE | Hot Stocks17:08 EDT Expedia sees FY18 adjusted EBITDA growth of 6%-11% - "I am excited to report that Expedia began 2018 firmly on a path toward faster growth and greater share gains in the $1.6 trillion travel industry. Over the past several months, we have made key organizational changes, aligned our company around common objectives and began executing on a new direction aimed at accelerating the geographic expansion of our global travel platform," said CEO Mark Okerstrom. "We are now operating with a clear focus on our highest priority markets, making concentrated investments across the platform including a step function change in our pace of adding new properties to our marketplace. These efforts combined with the impact of our ongoing cloud migration result in expectations for full year 2018 Adjusted EBITDA growth of 6% to 11%"
|
EXPE | Hot Stocks17:06 EDT Expedia down 19% to $100.00 after Q4 results miss estimates
|
ATVI | Hot Stocks17:05 EDT Activision Blizzard: Pipeline also about new content for existing games - Says games pipeline about more than just new games, it's also about new content for existing live games. Says had "impressive" audience per minute on opening day of Overwatch League. Says happy that so many brands partnered with Overwatch League teams. Says "pleased" with Overwatch League viewership so far.
|
ATVI | Hot Stocks16:59 EDT Activision Blizzard sees Q1 net bookings $1.28B
|
ATVI | Hot Stocks16:58 EDT Activision Blizzard sees Overwatch League profitable in 2018 - Says heading into 2018 with a "strong" balance sheet. Says tax reform allows company to repatriate cash more efficiently. Sees each segment growing in 2018. Sees in-game net bookings growth in 2018. Sees Blizzard growing year-over-year due to the release of a "World of Warcraft" expansion. Sees Overwatch League being profitable in 2018.
|
ATVI | Hot Stocks16:55 EDT Activision Blizzard raises quarterly dividend 13% to 34c per share - Activision Blizzard said its board of directors declared a cash dividend of 34c per common share, payable on May 9, 2018 to shareholders of record at the close of business on March 30, 2018, which represents a 13% increase from 2017. Additionally, the board of directors authorized over $1Bof further debt paydown during 2018.
|
CNS | Hot Stocks16:54 EDT Cohen & Steers reports preliminary AUM $61.3B as of January 31
|
JAZZ | Hot Stocks16:52 EDT Jazz Pharmaceuticals: NCCN adds Vyxeos to NCCN Guidelines for AML - Jazz Pharmaceuticals announced that the National Comprehensive Cancer Network added Vyxeos liposome for injection to the Clinical Practice Guidelines in Oncology for Acute Myeloid Leukemia. The United States FDA approved Vyxeos on August 3, 2017 for the treatment of adults with two types of AML, a rapidly progressing and life-threatening blood cancer.
|
JCI | Hot Stocks16:50 EDT Johnson Controls Federal Systems partners with U.S. Army - Johnson Controls Federal Systems is partnering with the U.S. Army Engineering and Support Center to implement energy conservation measures at the U.S. Army Garrison Kwajalein as part of a multi phased program to provide much needed Energy Resiliency and Facility upgrades to the installation. The $40M Energy Savings Performance Contract awarded for this Phase 1 project includes the design, implementation and long term operation of an island wide Solar PV/Lithium-ion Battery Storage/Microgrid control system and the installation of LED lighting systems at the site. The LED upgrades will reduce existing lighting energy costs by 64% and the Solar PV/Battery Storage application will reduce diesel usage by 55% for the island of Meck. The Johnson Controls Distributed Energy Storage team developed an integrated battery solution that can be replicated across the Department of Defense. The project enables the site to facilitate the use of renewables inside an existing utility grid that relied primarily on fossil fuel-based solutions.
|
SNPS | Hot Stocks16:49 EDT Synopsys acquires PhoeniX Software, terms not disclosed - Synopsys completed its acquisition of PhoeniX B.V., headquartered in Enschede, the Netherlands, a global supplier of photonic chip design solutions. With the acquisition, Synopsys is the leading provider of photonic integrated circuit design automation solutions for a wide range of application requirements ranging from data communications to sensors and biomedical devices. The terms of the deal, which is not material to Synopsys financials, are not being disclosed.
|
ATVI AMZN | Hot Stocks16:48 EDT Activision Blizzard says had 7 of top 20 games on Twitch in 2017 - Says Blizzard's (ATVI) "Hearthstone" gaining more DAUs. Says had 7 of the top 20 games on Twitch (AMZN) in 2017. Says King subsidiary biggest contributor to net bookings in 2017. Says Blizzard segment reported record annual segment revenues and operating income for a year with no major game release.
|
MAT | Hot Stocks16:48 EDT Mattel names Ynon Kreiz as Non-Executive Chairman of Board - Mattel announced that its Board of Directors has appointed Ynon Kreiz, a director of Mattel since June 2017, as Non-Executive Chairman of the Mattel Board of Directors, effective at the 2018 Annual Meeting of Stockholders. Kreiz succeeds Christopher Sinclair, the Executive Chairman of the Mattel Board and former CEO of Mattel, who on June 13, 2017, announced his intention to retire at the end of his term.
|
TMST | Hot Stocks16:47 EDT TimkenSteel announces price increase on certain bar products - TimkenSteel announced it will increase prices on special bar quality hot-rolled bar products by $40 per ton, as well as on SBQ hot-rolled and thermal-treated bar products by $50 per ton. This increase is effective with shipments beginning April 1, 2018. All surcharge mechanisms remain in effect.
|
ATVI | Hot Stocks16:46 EDT Activision Blizzard reports Q4 impact of GAAP deferrals 45c
|
ATVI | Hot Stocks16:43 EDT Activision Blizzard says next 'Call of Duty' game to be made by Treyarch - Says saw strong "Call of Duty" momentum. Says King subsidiary returned to growth in Q4. Says builing Overwatch League for the long-term. Says "Call of Duty" series continues to be "healthy" and "vibrant." Says next "COD" game to be made by Treyarch, who made the "Black Ops" games. Comments taken from Q4 earnings conference call.
|
ATVI | Hot Stocks16:41 EDT Activision Blizzard says next 'Call of Duty' game to be another 'Black Ops' - Says saw strong "Call of Duty" momentum. Says King subsidiary returned to growth in Q4. Says builing Overwatch League for the long-term. Says "Call of Duty" series continues to be "healthy" and "vibrant." Comments taken from Q4 earnings conference call.
|
SD | Hot Stocks16:41 EDT SandRidge Energy announces departures of CEO and CFO - The independent directors of SandRidge Energy announced that, "in light of our new strategic direction, discussions with large shareholders and robust deliberation among the independent members of the Board, now is the right time to begin transitioning to a new leadership team." James Bennett, the company's President and CEO, will depart from the company, effective February 8. Bill Griffin, who currently serves as an independent director, has agreed to serve as Interim President and CEO while the company conducts a full review of internal and external candidates. While serving as the Interim President and CEO, Griffin will continue to serve as a member of the Board. Julian Bott, the company's CFO, will also depart from the company, effective at the close of business on the date of filing the company's 2017 Annual Report on Form 10-K. Mike Johnson, the company's Chief Accounting Officer, has agreed to serve as Interim CFO. John Suter will continue in his role as Chief Operating Officer and Philip Warman will remain as General Counsel with an expanded role as an Executive Vice President. The Board has accepted the recommendation of its Nominating and Governance Committee to appoint Sylvia Barnes as an independent member of the Board. The Board will continue to have four independent directors with the appointment of Barnes, who "has valuable experience in capital markets, the energy industry and serving as a director on a public board," the company said.
|
AMOT | Hot Stocks16:41 EDT Allied Motion awarded $70M contract for Vehicle Market solutions - Allied Motion Technologies announced that it recently won the nomination for an approximate $70 million award to provide a customer-specific solution for the Company's Vehicle market, primarily in Europe. Revenue for the application is expected to begin ramping in 2020 and be substantially completed in 2028. This award is in addition to the previously disclosed Vehicle market awards received since May 2017, and brings the total awards received for Vehicle Market solutions to over $225 million, an average of approximately $32 million in revenue per year over about seven years.
|
GLUU | Hot Stocks16:39 EDT Glu Mobile sees Q1 bookings $72M-$74M - Sees FY18 bookings $325M-$335M.
|
SD | Hot Stocks16:39 EDT SandRidge Energy announces departures of CEO and CFO
|
SD | Hot Stocks16:38 EDT SandRidge board approves 2018 budget with capital expenditures of $180M-$190M - SandRidge Energy issued a letter to update shareholders on its strategic objectives, stating in part: "The Company's Board of Directors has approved the Company's budget for 2018, which includes $180-$190 million in total capital expenditures, down from $247 million in 2017. The Company will continue a one-rig program in the NW STACK of the Mid-Continent substantially funded by a development agreement that provides an initial $100 million of capital from our financial partner. The Company will also continue a one-rig drilling program in North Park Basin. Both programs are designed to delineate and advance our NW STACK and North Park Basin assets to full field development...Consistent with the need for superior financial discipline, the Company is in the process of instituting changes in the organization structure to efficiently execute our strategic objectives. These changes are expected to reduce our ongoing G&A cash expenses by one-third to $36-$39 million per year. At these new levels of expense, G&A will have been cut by more than half since the Company's emergence from bankruptcy in October 2016."
|
OLED | Hot Stocks16:35 EDT Universal Display, Govisionox announce OLED evaluation agreement - Universal Display Corporation announced an OLED evaluation agreement with Kunshan Govisionox Optoelectronics Co., Ltd. Under this agreement, Universal Display will supply Govisionox with its proprietary UniversalPHOLED phosphorescent OLED materials for display applications. Details and financial terms of the agreement have not been disclosed.
|
CRSP | Hot Stocks16:34 EDT Crispr announces Chief Scientific Officer Bill Lundberg stepping down - Crispr Therapeutics announced that Bill Lundberg, MD, is stepping down as Chief Scientific Officer of CRISPR. Going forward, Lundberg will serve as a Senior Advisor to the company and has been named head of Crispr's Scientific Advisory Board.
|
FOR | Hot Stocks16:32 EDT Forestar Group sells development projects to Starwood for $232M - Forestar Group announced a strategic asset sale for $232M to a joint venture between an affiliate of Starwood Capital Group and an affiliate of Land Strategies Management. The strategic sale includes 20 legacy community development projects owned both directly and indirectly through ventures primarily consisting of approximately 750 developed and under development lots and over 4,000 future undeveloped lots, 730 unentitled acres and an interest in 1 multifamily operating property. The transaction is not expected to have a material impact on Forestar's fiscal 2018 earnings.
|
SXT | Hot Stocks16:31 EDT Sensient to acquire natural color business of GlobeNatural - Sensient Technologies announced that it has reached a definitive agreement to acquire the natural color business of GlobeNatural, a natural food and ingredient company based in Lima, Peru, owned by the Michell Group. The transaction is expected to close in the first quarter of 2018. The new entity will operate as Sensient Natural Colors Peru S.A.C.
|
WWW | Hot Stocks16:29 EDT Wolverine World Wide raises quarterly dividend 33% to 8c from 6c per share - The dividend is payable on May 1 to stockholders of record on April 2.
|
WWW | Hot Stocks16:28 EDT Wolverine World Wide sees FY17 remediation costs of $30M-$35M - Over the last year, the Company has been working through a legacy issue related to its former Tannery operation and related disposal sites. The Company is cooperating with local, state, and federal authorities to evaluate these sites for the presence and impact of PFOA and PFOS, two of the family of compounds known as per- and polyflouroalkyl substances. PFOA and PFOS were used for many decades in commercial products like firefighting foams and metal plating, and in common consumer items like food wrappers, microwave popcorn bags, pizza boxes, Teflon, carpets, and 3M's Scotchgard(TM). Due to their widespread use over such a long period of time, PFOA and PFOS can be found virtually everywhere and in everyone to some degree. Like thousands of other companies and millions of consumers, the Company purchased Scotchgard(TM) from 3M and relied on 3M's assurances to Wolverine, the EPA, FDA, scientific bodies, and the public that there were no adverse effects on human health from Scotchgard(TM) containing PFOA and PFOS - a position 3M maintains today. Despite decades of study and millions of dollars of research, human health effects from PFOA and PFOS are unknown, and no human studies have proven that exposure by an individual to PFOA or PFOS causes any illness. Wolverine's former tannery operations closed in 2009, and over the last year the Company has been working with state, local, and federal authorities to test area groundwater for the possible presence of PFOA and PFOS. Wolverine has taken proactive and immediate steps to provide drinking water solutions for impacted residents in our community while more testing and evaluation is completed. The actions taken by the Company have been beyond those voluntarily taken by other companies or the federal government facing similar circumstances. The Company is working in full cooperation with federal, state and local officials to address these legacy issues, and it will continue to be part of the long-term solution to provide our community the confidence it deserves in its drinking water. Based on the actions taken and the ongoing testing and monitoring currently expected to take place in the future to comply with recent regulatory actions, the Company expects to accrue environmental remediation costs of $30 million to $35 million ($0.24 to $0.28 per share) in fiscal 2017, of which $13 million to $16 million is expected to be paid in fiscal 2018 with the remainder to be paid in 2019 and beyond. In addition to environmental remediation costs estimated here, the Company expects to incur $8 million to $12 million in fiscal 2018 for legal, consulting and other costs related to this legacy environmental issue. The environmental costs discussed are estimates and actual amounts could differ significantly in the future as circumstances evolve. The Company has not reserved amounts for any non-remediation related legal claims related to this matter, as such amounts cannot be estimated at this time. The Company intends to pursue recovery of environmental remediation costs incurred from other parties including insurance carriers that provided coverage during the relevant periods. The above cost estimates do not include any possible future recovery from these parties.
|
NVDA | Hot Stocks16:28 EDT Nvidia up 6% after earnings report and guidance - In after-hours trading, Nvidia is up $12.98, or 6%, to $230.50.
|
CIVI | Hot Stocks16:26 EDT Civitas Solutions approves stock buyback of up to $25M - On February 7, 2018, Civitas Solutions' board approved a stock repurchase program under which the company is authorized to repurchase up to $25M of the company's outstanding common stock from time to time in the open market, through negotiated transactions or otherwise. The stock repurchase program will expire on August 12, 2018. The company intends to conduct any open market stock repurchase activities in compliance with the safe harbor provisions of Rule 10b-18 of the Exchange Act.
|
MOBL | Hot Stocks16:26 EDT MobileIron's IT management platform selected by German regional Red Cross - MobileIron's platform will be used by the German Red Cross of Rhineland-Palatinate to manage Windows laptops and smartphones. The Rhineland-Palatinate chapter will use MobileIron Bridge, a solution that allows mobile devices, laptops and desktops running Windows 10 to be managed via a single central console and communication channel. The management console, which has already been applied to smartphones, will ultimately handle some 200 laptops.
|
TX | Hot Stocks16:25 EDT Ternium announces agreement with NSSMC regarding Usinas governance - Ternium announced that its subsidiary Ternium Investments entered into a binding and immediately effective agreement with Nippon Steel & Sumitomo Metal Corporation, establishing certain new governance rules for Usinas Siderurgicas de Minas Gerais S.A. - Usiminas as well as certain undertakings for the settlement of legal disputes. The new governance rules for Usiminas include, among others, an alternation mechanism for the nomination of each of the CEO and the chairman of the board, as well as a new mechanism for the nomination of other members of Usiminas' executive board. In addition, the agreement incorporates an exit mechanism. The agreement includes an exit mechanism consisting of a buy-and-sell procedure. Such buy-and-sell procedure would allow either Ternium or NSSMC to purchase all or a majority of the Usiminas shares held by the other party. As part of this agreement, Ternium and NSSMC will take all necessary steps to amicably terminate or resolve all pending judicial and administrative disputes involving Ternium, NSSMC, their affiliates or Usiminas, as well as current and former members of Usiminas' managerial bodies, that have arisen in the past few years in connection with Usiminas, with a view to rebuilding their mutual trust and strengthening their joint partnership in Usiminas. Usiminas has been steadily improving its profitability and financial strength, as shown in recent financial statements, after overcoming certain financial difficulties by actively implementing various measures, including the optimization of its production structure, a capital increase and a debt restructuring. Ternium, together with NSSMC, is committed to moving forward with the turnaround of Usiminas and the enhancement of its competitiveness and corporate value in the best interest of Usiminas and all of its stakeholders.
|
WWW | Hot Stocks16:25 EDT Wolverine World Wide sees Q4 one time tax expense of about $9M - On December 22, 2017, the Tax Cuts and Jobs Act (TCJA) was passed, significantly changing U.S. tax law. This tax reform is expected to result in material positive benefits for Wolverine. The 2018 effective tax rate is expected to be in the range of 18% to 21%. This should result in a reduction in cash taxes of approximately $18 million to $20 million. In addition, the Company now expects to repatriate approximately $300 million of cash currently held in non-U.S. subsidiaries, and will now have the ability to repatriate future overseas cash balances with minimal U.S. tax cost. In the fourth quarter of fiscal 2017, the Company expects the TCJA to result in a one-time tax expense of approximately $9 million ($0.09 per share). This includes approximately $58 million related to the taxation of unremitted earnings of non-U.S. subsidiaries, which will be paid over 8 years, and $3 million of other related taxes. This is partially offset by a non-cash adjustment of $52 million to remeasure deferred tax balances at the new corporate rate. These estimates are preliminary because uncertainty remains regarding the impact of the TCJA as a result of factors including future regulatory and rulemaking processes, the prospects of additional corrective or supplemental legislation, potential trade or other factors.
|
HIG | Hot Stocks16:25 EDT Hartford Financial sees 2018 Commercial Lines combined ratio 93-95.5
|
NVDA | Hot Stocks16:22 EDT Nvidia sees returning $1.25B to shareholders in FY19 - During FY18, NVIDIA returned $1.25B to shareholders through a combination of $909M in share repurchases and $341M in quarterly cash dividends. For FY19, NVIDIA intends to return $1.25B to shareholders through ongoing quarterly cash dividends and share repurchases.
|
RGNX | Hot Stocks16:21 EDT REGENXBIO completes dosing of third cohort in Wet AMD trial - REGENXBIO announced it has completed dosing of the third cohort of six patients in a Phase I clinical trial evaluating RGX-314 for the treatment of patients suffering from wet age-related macular degeneration."We are excited about the progress that we have made in the clinical development of our lead product candidate, RGX-314," said Stephen Yoo, M.D., Chief Medical Officer of REGENXBIO. "Completing enrollment of the third cohort in the Phase I clinical trial brings us one step closer toward delivering on the promise of a one-time treatment with rapid and sustained therapeutic effects for patients with wet AMD, one of the largest indications for which gene therapy is being developed." Six leading retinal surgery centers across the United States are participating in the Phase I trial of RGX-314. This multi-center, open-label, multiple-cohort, dose-escalation clinical trial is designed to assess the safety and tolerability of RGX-314 as a one-time therapy for patients with previously treated wet AMD. REGENXBIO plans to share topline results from the Phase I trial in late 2018.
|
RAD WBA | Hot Stocks16:20 EDT Rite Aid completes over half of planned store transfers - Rite Aid Corporation (RAD) provided an update on the progress of its plans to sell stores to Walgreens Boots Alliance (WBA) pursuant to the previously disclosed Amended and Restated Asset Purchase Agreement, dated as of September 18, 2017. As of February 8, 2018, Rite Aid has transferred 1,114 stores and related assets to WBA, and has received cash proceeds of $2,424 million, which the Company continues to use to reduce debt. Under the Asset Purchase Agreement, WBA will purchase a total of 1,932 stores, three distribution centers and related inventory from Rite Aid for an all-cash purchase price of $4,375 million on a cash-free, debt-free basis. "We have now completed more than half of the planned store transfers and remain on track to finish the process in the spring of this year," said Rite Aid Chairman and CEO John Standley. "As we work to complete this process, we remain focused on opportunities to build our business while delivering a great experience to our customers and patients and driving value for our shareholders." The majority of the closing conditions have been satisfied, and the subsequent transfers of Rite Aid stores and related assets remain subject to minimal customary closing conditions applicable only to the stores being transferred at such subsequent closing, as specified in the Asset Purchase Agreement.
|
NCR | Hot Stocks16:20 EDT NCR Corp. announces plans for $300M in share repurchases in 2018 - During 2018, NCR plans to repurchase up to $300M of its common stock under its previously authorized share repurchase programs, and has repurchased shares of its common stock for approximately $125M through the date of this release.
|
UAL | Hot Stocks16:19 EDT United Continental still expects Q1 passenger unit revenue flat-up 2% - United Continental continues to expect Q1 consolidated passenger unit revenue to be flat to up 2.0% compared to the Q1 of 2017.
|
MRCY | Hot Stocks16:19 EDT Mercury Systems receives $2M order - Mercury Systems announced it has received an initial $2.0M order for an Electro-Optic/Infra-Red image processing subsystem from a major defense prime contractor. The subsystem is an enterprise architecture solution designed to apply to multiple programs and missions. The order was booked in the company's Q2 and is expected to be shipped over the next several quarters.
|
UAL | Hot Stocks16:19 EDT United Continental reports January consolidated traffic up 1.8% - United Continental reports January consolidated traffic increased 1.8% and consolidated capacity increased 3.3% versus January 2017. UAL's January 2018 consolidated load factor decreased 1.2 points compared to January 2017.
|
SKX | Hot Stocks16:17 EDT Skechers authorizes up to $150M share buyback program - In February 2018, Skechers' board of directors authorized a stock repurchase program, under which the company plans to repurchase up to $150M of its Class A common stock through February 8, 2021 in the open market at prevailing prices. Under the repurchase program, repurchases can be made from time to time using a variety of methods, which may include open market purchases, privately negotiated transactions or otherwise, all in accordance with the United States Securities and Exchange Commission and other applicable legal requirements. The specific timing, price and size of purchases will depend on prevailing stock prices, general economic and market conditions, and other considerations. The repurchase program does not obligate the Company to acquire any particular amount of Class A common stock, and the repurchase program may be suspended or discontinued at any time at the Company's discretion.
|
COLM | Hot Stocks16:16 EDT Columbia Sportswear raises quarterly dividend 16% to 22c per share - The board of directors authorized a 16 percent increase in the regular quarterly dividend from $0.19 to $0.22 per share, payable on March 22, 2018 to shareholders of record on March 9, 2018.
|
BNED | Hot Stocks16:14 EDT Barnes & Noble Education expands relationship with McGraw-Hill - Barnes & Noble Education announced an expanded relationship with McGraw-Hill Education, which will provide students, faculty and institutions with greater access to more affordable course materials. The companies will partner on two initiatives: the distribution of McGraw-Hill Education e-content through inclusive access models on campuses served by BNED, and the distribution of McGraw-Hill Education's new rental titles through BNED channels. Inclusive access models, including Barnes & Noble College's First Day model, offer course materials at reduced prices through a course materials fee for participating courses or programs. These models ensure students receive their materials on or before the first day of class, and have a proven track record of driving positive outcomes for students. Barnes & Noble Education and McGraw-Hill Education will partner to make McGraw-Hill Education content available through inclusive access programs offered at the nearly 1,485 schools served by Barnes & Noble Education.
|
UPS | Hot Stocks16:13 EDT UPS increases dividend almost 10% - The UPS board declared an increased regular quarterly dividend of 91c per share on all outstanding Class A and Class B shares, an increase of nearly 10% over the prior dividend. The dividend is payable March 7 to shareowners of record on February 20.
|
EXPE | Hot Stocks16:13 EDT Expedia reports Q4 adjusted EBITDA down 9% y/y - Reports Q4 adjusted net income down 28% y/y; free cash flow down 90% y/y.
|
WWD BA | Hot Stocks16:11 EDT Woodward says 'not in discussions with Boeing over a possible acquisition' - There are various articles originating from a Wall Street Journal article stating, "Boeing Co. is in talks to buy aerospace parts maker Woodward Inc., according to people familiar with the matter." This rumor is incorrect. Woodward is not in discussions with Boeing over a possible acquisition of Woodward, and will not provide any further comment on this story.
|
MPWR | Hot Stocks16:11 EDT Monolithic Power increases dividend to 30c from 20c per share - Monolithic Power announced that its Board of Directors has approved an increase in its quarterly cash dividend from 20c per share to 30c per share. The first quarter dividend of 30c per share will be paid on April 13 to all stockholders of record as of the close of business on March 30.
|
QCOM AVGO | Hot Stocks16:09 EDT Qualcomm board unanimously rejects Broadcom's proposal - Qualcomm announced that its Board of Directors has unanimously rejected the revised non-binding, unsolicited proposal by Broadcom (AVGO) to acquire all of the outstanding shares of Qualcomm for $82.00 per share ($60.00 in cash and $22.00 in Broadcom stock), which Broadcom announced on February 5, 2018. The Qualcomm Board, assisted by its financial and legal advisors, determined that the Broadcom proposal materially undervalues Qualcomm and falls well short of the firm regulatory commitment the Board would demand given the significant downside risk of a failed transaction. However, Qualcomm has offered to meet with Broadcom to see if it can address the serious deficiencies in value and certainty in its proposal.
|
QGEN | Hot Stocks16:06 EDT Qiagen's QuantiFERON-TB Gold Plus gains approval in Japan - QIAGEN N.V. announced that Japan's Ministry of Health Labor and Welfare has approved QuantiFERON-TB Gold Plus as an in vitro diagnostic to detect tuberculosis infection. QFT-Plus is the fourth generation of QIAGEN's market-leading QuantiFERON-TB technology, combining innovative CD4+/CD8+ design for comprehensive immune response detection with the most flexible blood collection workflow for efficient screening in large-scale TB control programs. Japan's approval of QFT-Plus follows 2017 approval in the United States and successful uptake of the test in more than 75 countries across Europe, the Middle East, Africa, Asia and Latin America, where nearly two million of the new tests have already been used. QFT-Plus builds on the foundation of QuantiFERON-TB Gold, the third generation of QIAGEN's world-leading interferon gamma release assay.
|
EXPE | Hot Stocks16:06 EDT Expedia reports Q4 room night growth down 757 bps
|
EXPE | Hot Stocks16:05 EDT Expedia reports Q4 gross bookings up 14% y/y
|
XLRN | Hot Stocks16:04 EDT Acceleron names Sujay Kango chief commercial officer - Acceleron Pharma announced the appointment of commercial industry leader, Sujay Kango as Chief Commercial Officer. He brings over 25 years of commercial leadership and expertise, in both biotechnology and large pharmaceutical companies. Throughout his career, Mr. Kango has led multiple global product launches, including Kyprolis and Remicade, built commercial teams, and also served in collaboration leadership roles for both the Onyx Pharmaceuticals-Bayer and Infinity Pharmaceuticals-AbbVie partnerships.
|
ALGN | Hot Stocks16:02 EDT Align Technology patent affirmed by panel - Align Technology announced that on February 5, a three-judge panel of the Patent Trial and Appeal Board entered its decision refusing to institute an inter partes review trial proceeding sought by ClearCorrect to challenge the patentability of Align's patent no. 8,038,444, entitled "Automated Treatment Staging for Teeth." The decision found that ClearCorrect had failed to show a reasonable likelihood that any of the 42 claims in the '444 patent were unpatentable, and thus the panel unanimously refused to institute the trial proceeding requested by ClearCorrect.
|
BIOA | Hot Stocks15:57 EDT BioAmber trading resumes
|
CME | Hot Stocks15:52 EDT CME Group CEO sells 20,000 Class A common shares - In a regulatory filing, CME Group chairman and CEO Terrence A. Duffy disclosed the sale of 20,000 shares of Class A common stock at a price of $151.66 per share.
|
HMNY | Hot Stocks14:51 EDT Helios and Matheson's MoviePass surpasses 2M subscribers - MoviePass, a majority-owned subsidiary of Helios and Matheson Analytics, announced that MoviePass has exceeded 2M subscribers "less than one month after announcing its milestone of 1.5M subscribers." Mitch Lowe, CEO of MoviePass, said, "Based on the dramatic increase in the number of MoviePass subscribers over such a short period of time, we believe MoviePass will continue to grow its subscriber base significantly."
|
LMT | Hot Stocks14:09 EDT Lockheed Martin receives $524M for PAC-3 missiles - The United States and allied military forces will upgrade their missile defense capabilities under a $524M contract modification for production and delivery of Lockheed Martin Patriot Advanced Capability-3 and PAC-3 Missile Segment Enhancement interceptors. This modification is in addition to the $944M contract awarded on Dec. 21, 2017 for PAC-3 and PAC-3 MSE production and delivery. The contract modifications include PAC-3 and PAC-3 MSE missile deliveries, launcher modification kits, associated equipment and spares.
|
ABEO | Hot Stocks14:04 EDT Abeona reports top-line data from Phase 1/2 gene therapy trial in MPS IIIA - Abeona Therapeutics announced updated clinical data from the ongoing Phase 1/2 trial for ABO-102, the company's investigational gene therapy for the treatment of Sanfilippo syndrome Type A, or MPS IIIA, a rare autosomal-recessive lysosomal storage disease. The company said the results demonstrate robust and durable clinical effects achieved throughout various timepoints post-administration. To date, 10 patients have been dosed with a single intravenous injection of ABO-102. Results were reported today during the WORLDSymposium for Lysosomal Diseases. ABO-102 continues to show evidence of stabilization or improvement in cognitive function at six months in Cohort 2 and one year in Cohort 1. Two of the three treated patients from Cohort 2 showed evidence of improvement in the Leiter-R non-verbal IQ and stabilized Vineland scales, the company said. "Results thus far from the ongoing ABO-102 clinical trial support the tolerability of a systemically delivered AAV approach for the treatment of lysosomal storage diseases. The large reductions in heparan sulfate in both CSF and urine, significant organ changes and demonstration of neurocognitive benefits represent important findings that support our path to regulatory guidance later this year. Importantly, the FDA recently allowed the lowering of the enrollment age to include subjects as young as 6 months, supporting the clinical paradigm of treating subjects earlier in their disease manifestation," stated CEO Timothy Miller.
|
TRNC | Hot Stocks13:48 EDT Moody's says tronc sale of LATimes and San Diego Union-Tribune credit positive - Moody's Investors Service said that it views tronc announced sale of the Los Angeles Times, The San Diego Union-Tribune and other titles in the California News group to Nant Capital as a credit positive and expects tronc to use a material portion of asset sale proceeds towards debt repayment. Combined with the acquisition of BestReviews, the announced transactions strengthen tronc 's digital strategy and provide for de-levering opportunity. There is no immediate impact on the company's credit ratings.
|
GOOS KORS | Hot Stocks13:22 EDT Canada Goose falls following Q3 results amid new CFO appointment - Shares of outerwear company Canada Goose Holdings (GOOS) are falling despite better-than-expected quarterly results and the appointment of a new chief financial officer. EARNINGS: On Thursday, Goose Holdings reported third quarter adjusted earnings per share of C58c on a revenue of C$265.8M, beating analysts' estimates of C48c and C$248M, respectively. Total revenue increased by C$56.8M from C$209.1M in 2016 in Q3, representing year-over-year growth of 27.2%. EXECUTIVE COMMENTARY: "In our peak selling season, we delivered strong performance across geographies, channels and categories this quarter, reflecting the continued demand for the Canada Goose brand around the world. Year to date, we added e-commerce sites in seven new markets, opened five new stores across three continents, including our partner operated store in Tokyo, and we successfully added more than 700 employees. As we look ahead, we continue to build deeper relationships with our fans and bring new people into the world of Canada Goose," stated Dani Reiss, president and chief executive officer. CFO APPOINTMENT: Canada Goose also announced Thursday that Jonathan Sinclair will succeed John Black as CFO and executive vice president and is expected to join the company toward the middle of the year. Black has informed the company of his intention to retire and will continue as CFO until Jonathan's appointment. He will remain in a senior role until the end of year to ensure a smooth transition. Sinclair currently serves as CFO of business operations at Jimmy Choo, recently acquired by Michael Kors (KORS). ANALYST COMMENTARY AHEAD OF EARNINGS: On Tuesday, Canaccord analyst Camilo Lyon raised his price target on Canada Goose to C$50 from C$36 ahead of the quarterly results. The analyst cited recent checks that showed demand in both retail and online remains robust. He believes the more important aspect is whether the company can meet the current demand. Lyon reiterated his Buy rating on Canada Goose shares. Additionally, Barclays analyst Jim Durran raised his price target for Canada Goose to $39 from $28 and kept an Overweight rating on the shares on Monday. Colder than average winter weather will contribute to accelerated DTC development this year and over the next two years, which should drive sustained higher valuation multiples, he said. PRICE ACTION: Canada Goose is off earlier lows, dropping nearly 16%, or $6.01, to $32.20 in afternoon trading.
|
TTWO... | Hot Stocks13:21 EDT Analysts positive on Take-Two after Q3 earnings despite revenue miss - Shares of Take-Two Interactive (TTWO) slid after the game maker reported lower than expected quarterly results last night. Following the report, however, several analysts gave positive views on the stock. WHAT'S NEW: After the market close on Wednesday, Take-Two reported third quarter GAAP earnings per share of 21c on net bookings, its adjusted revenue metric, of $653.9M, compared to analysts' estimates for 98c and $663.83M, respectively. In addition, the company guided for fourth quarter GAAP EPS of 73c-83c on net bookings of $410M-$460M, compared to the consensus estimates of 59c and $442.08M, respectively. Take-Two also updated its outlook for fiscal 2018, raising its FY18 EPS view to $1.50-$1.60 from 55c-80c and boosted its FY18 revenue view to $1.8B-$1.85B from $1.74B-$1.84B. Analysts currently expect the company to report FY18 EPS of $3.07 and revenue of $2.02B. WHAT'S NOTABLE: The quarterly report comes a week after the company's Rockstar division delayed the release of its upcoming Western action game "Red Dead Redemption 2" to October 26, 2018, from its prior launch window of Spring 2018. On its quarterly earnings conference call, Take-Two Chief Executive Officer Strauss Zelnick said that he is "confident" that October 26 will be the game's release date. STREET RESEARCH: Following the earnings report, Barclays analyst Ryan Gee backed an Overweight rating on Take-Two and raised his price target on the shares to $128 from $121. The analyst said that the higher run-rate for both "Grand Theft Auto Online" and "NBA 2K18" exiting Q3 provides a larger base of high-margin revenue to layer additional titles and content, and that he thinks the company is well-positioned to approach the margins level of its peers once the title slate really begins to fill out in fiscal 2019 with "Read Dead Redemption 2" and a new 2K title. In addition, Wedbush analyst Michael Pachter reaffirmed a Neutral rating on the stock, but raised his price target on the share to $126 from $95, saying that Take-Two has consistently delivered upside to guidance and consensus, making its shares attractive over the near term. Pachter noted, however, that his firm is not willing to recommend the shares due to an unclear long-term release slate. Meanwhile, Baird analyst Colin Sebastian reiterated his Outperform rating and $137 price target on Take-Two shares and recommended being a buyer on any weakness. The analyst said that the game maker reported solid Q3 results and added that the fundamentals remain positive given the digital transition and strong product sales. PRICE ACTION: In afternoon trading, Take-Two is down 9.4% to $106.25. OTHERS TO WATCH: Rival Electronic Arts (EA), which reported quarterly results last week, fell 2.5% in afternoon trading, while Activision Blizzard (ATVI) is down 3.3% ahead of its quarterly report after today's market close.
|
UNP | Hot Stocks13:17 EDT Union Pacific boosts quarterly dividend by 10% to 73c - Union Pacific announced that its board voted to increase the quarterly dividend on the company's common shares by 10% to 73c per share. The increased dividend is payable March 30, to shareholders of record as of February 28. "This is the second consecutive quarterly dividend increase for Union Pacific shareholders," said Rob Knight, Union Pacific's CFO, "and is part of our ongoing evaluation of how best to use the benefits of tax reform legislation."
|
SPPI | Hot Stocks12:59 EDT Primecap reports 5.63% passive stake in Spectrum
|
NYT | Hot Stocks12:36 EDT NYT says total digital-only subscription revenue for Q4 was $96M, up 40% YoY - Total digital-only subscription revenue for Q4 was $96M. The quarter had 14 weeks. Once adjusted, so it can be compared like-for-like with the 13 quarter a year earlier, that represents an increase of 40% year-over-year.
|
PLAY | Hot Stocks12:36 EDT Wellington Management reports 8.93% passive stake in Dave & Buster's - In a regulatory filing, Wellington Management disclosed an 8.93% stake in Dave & Buster's, representing 3,635,488 shares. The filing does not allow for activism.
|
NYT | Hot Stocks12:32 EDT New York Times says digital revenue grew by 11.5% for 2017 vs. 2016
|
NYT | Hot Stocks12:28 EDT NYT says total digital-only subscription revenue for Q4 was $96M - During its Q4 earnings conference call executives for the company said that total digital-only subscription revenue for Q4 was $96M The quarter had 14 weeks. Once adjusted, so it can be compared like-for-like with the 13 quarter a year earlier, that represents an increase of 40% year-over-year. Print subscription and single copy revenue was $173M, less than 0.5% point year-over-year decline on the same adjusted like-for-like basis.Digital advertising performed slightly better than expected, ending the quarter at $84 million, which represented -- represents an adjusted like-for-like increase of 1%.
|
FIT | Hot Stocks12:23 EDT DNB Asset Management reports 8.6% passive stake in Fitbit
|
ABEO | Hot Stocks12:15 EDT Abeona Therapeutics treatment of CLN1 granted FDA orphan status - Abeona Therapeutics' treatment of neuronal ceroid lipofuscinosis type 1 or CLN1, was granted FDA orphan designation, according to a post to the agency's website. Reference Link
|
SHPG | Hot Stocks12:13 EDT Shire pediatric Crohn's treatment granted FDA orphan status - Shire's treatment of Crohn's Disease in the pediatric population was granted FDA orphan designation, according to a post to the agency's website. Reference Link
|
FLT | Hot Stocks12:02 EDT Wellington Management reports 5.76% passive stake in FleetCor - In a regulatory filing, Wellington Management disclosed a 5.76% stake in FleetCor Technologies, representing 5,167,686 shares. The filing does not allow for activism.
|
CBOE | Hot Stocks11:40 EDT CBOE says will be listing exchange for upcoming Vanguard ETF launches - Cboe Global Markets tweeted from its official Twitter account, "Proud to be named the listing exchange for @Vanguard_Group's upcoming ETF launches" with a link to a filing related to the news. Reference Link
|
THO THR | Hot Stocks11:20 EDT Correction: Thor Industries did not issue FY18 revenue guidance this morning - Thor Industries (THO) announced yesterday that the preliminary date for its fiscal 2018 second quarter earnings release will be March 7 after market close. The final release date will be confirmed approximately one week prior to the release, the company stated. This note corrects a prior one that was issued regarding Thermon Group (THR) that was erroneously tagged as being related to Thor.
|
BDRBF | Hot Stocks11:15 EDT Bombardier says not selected as preferred bidder for RSSOM contract - Bombardier Transportation confirms that it has not been selected as preferred bidder for the provision of rolling stock, systems, operation and maintenance services, or RSSOM Contract, for Montreal's Reseau electrique metropolitain, or REM, project. "We understand and share the disappointment our employees have about this announcement. Bombardier has been providing innovative transportation solutions in Quebec and elsewhere in Canada for close to 45 years. As world leader in the supply of automated transportation systems and services, and operation of public transit fleets, we believe that the offer we submitted was both very competitive and ideally suited to meet the sustainable mobility needs of the greater Montreal area", said Benoit Brossoit, President, Bombardier Transportation, Americas Region.
|
TSLA | Hot Stocks10:53 EDT Tesla sliding despite better than expected quarter as Model 3 concerns remain - Shares of Tesla (TSLA) are slipping despite announcing smaller than expected quarterly losses and saying it is sticking to its latest Model 3 production targets. While some Wall Street analysts raised their price targets on the shares following the electric carmaker's report of results, other remain concerned over the ramp-up of the Model 3 and the company's cash burn. RESULTS: Last night, Tesla reported a fourth quarter loss per share of ($3.04) and revenue of $3.29B, above consensus of ($3.12) and $3.28B, respectively. Tesla also announced fourth quarter deliveries of 29,967 vehicles, including 1,542 Model 3s, and said it still targets weekly Model 3 production rates of 2,500 by end of the first quarter and 5,000 by the end of the second quarter. The carmarker added that Model 3 net reservations remained stable in Q4, and notes it sees Model S and Model X deliveries of about 100,000 in 2018. PRICE TARGET RAISED: Following the quarterly report, Piper Jaffray analyst Alexander Potter raised his price target for Tesla to $385 from $362 saying he thinks most of the news in the fourth quarter was positive. Model 3 production delays had already been disclosed last quarter, and apparently no new problems have arisen in recent months, Potter noted, adding that this suggests a production run-rate of 5,000 units per week may be achievable in 2018. Additionally, the analyst pointed out that cash flow was "solid," with Tesla seeming confident that positive operating income can be achieved at some point in 2018. He reiterated an Overweight rating on the shares. His peer at Deutsche Bank also raised his price target for Tesla to $365 from $310, highlighting that its cash burn subsided in the quarter. One of the more noteworthy financial developments was that Tesla ended Q4 with $3.4B in cash, down just slightly from the $3.5B in Q3, analyst Rod Lache told investors. The analyst also believes that if Tesla's targets are reached, the company can achieve $28 per share in earnings by 2020. He reiterated a Hold rating on the shares. MODEL 3, CASH BURN CONCERNS REMAIN: In a research note to investors, UBS analyst Colin Langan argued that Tesla's fourth quarter beat was due to several one-time items, including ZEV credits and one-time working capital benefits, and said he is still cautious on the company's cash burn rate and Model 3 production ramp. Langan reiterated his Sell rating and $195 price target on the stock. His peer at Cowen voiced a similar opinion. Analyst Jeffrey Osborne said he believes production targets remain too aggressive, while pointing out that Model 3 deposits were flat quarter over quarter. Osborne reiterated an Underperform rating on the stock, but raised his price target on the shares to $200 from $180. Meanwhile, Jefferies analyst Philippe Houchois told investors in a research note of his own that he views Tesla's fourth quarter numbers as "reassuring overall" since free cash flow was better. However, the analyst believes the quarter is "somewhat reflected" in the recent share price recovery. He reiterated an Underperform rating and $240 price target on the stock. PRICE ACTION: In morning trading, shares of Tesla have dropped about 3.5% to $332.73.
|
WWD | Hot Stocks10:29 EDT Woodward trading resumes
|
WWD BA | Hot Stocks10:25 EDT Woodward jumps 13%, halted for volatility after report of Boeing takeover talks
|
WWD | Hot Stocks10:24 EDT Woodward trading halted, volatility trading pause
|
NS | Hot Stocks10:22 EDT NuStar Energy sees FY18 adjusted EBITDA $600M-$650M - Sees FY18 CapEx $360M-$390M. Comments taken from the Q4 earnings conference call. NuStar Energy is down 17.6% in morning trading to $25.50.
|
K | Hot Stocks10:05 EDT Kellogg expects Asia-Pacific to be growth driver in 2018 - Sees expanded brand support, steady consumption improvement, re-shaped P&L post-DSD in U.S. snacks in 2018. Sees stabilizing RTEC share, investing behind adult-segment brands, gradually improving sales performance for U.S. Morning Foods in 2018. Sees continued growth in sales and share in Specialty Channels. Sees North America momentum carrying into 2018 through frozen segment. Sees improving sales performance in cereal in Europe. Says will expand Parati in 2018. Sees stabilization in the Caribbean/Central America. Sees cereal and Pringles growth in Asia & Africa and continued growth in JVs in 2018.
|
PGC | Hot Stocks10:01 EDT Peapack-Gladstone to give $1,000 bonus to FT employees below exec. leadership - Peapack-Gladstone Financial announced that as a result of the reduction in corporate taxes from the Tax Cuts and Jobs Act, as previously announced in the company's Form 8-K dated January 18, 2018, the Company will reinvest up to 25% of that tax benefit in the company's people, processes, systems, client services and/or communities it serves. These benefits include, but are not limited to: Salary adjustments for the lower 25th percentile of staff based on salary level; A bonus of $1,000 to all full-time employees below the Executive Leadership Team level, with $500 given to all part-time employees; Approximately 20% increase in contributions and community support spending; Enhancing the company's online and mobile banking capabilities; Streamlining and automating our commercial loan origination and underwriting processes; and Expanding the Company's data analytics.
|
BIOA | Hot Stocks09:59 EDT BioAmber trading halted, news pending
|
CRM | Hot Stocks09:58 EDT Salesforce to invest $2B in Canadian business over next five years - Salesforce plans to invest $2B over the next five years to fuel the growth of its Canadian business, the company announced ahead of a meeting with Prime Minister Trudeau. As part of this investment, Salesforce plans to increase its headcount, real estate footprint and data center capacity to support its rapidly-growing customer base in the country.
|
K | Hot Stocks09:52 EDT Kellogg expects FY18 cash flow $1.2B-$1.3B - Says expects to increase cash flow in 2018. Sees FY18 net sales approximately flat. Sees approximately 1% negative impact from DSD Transition for FY18 net sales. Sees approximately 1%-2% positive impact from acquisition of RxBar on FY18 net sales. Sees FY18 adjusted operating profit up 4%-6%, currency neutral. Sees FY18 adjusted EPS up 9%-11%, currency neutral.
|
K | Hot Stocks09:42 EDT Kellogg says confident in return to 'solid, sustainable growth' - Says confident company will return to solid, sustainable growth. Says finished year on "sound financial footing", delivered on financial outlook. Says continues to expand Pringles across the globe. Says saw strong stabilization of core developed international cereal markets in 2H. Says expanding in emerging markets, eCommerce. Says 2018 plan includes completing Project K initiatives, boosting U.S. snacks post-DSD, increasing brand investment, integrating and growing RxBar, Parati, and investing to grow joint ventures. Says expects to achieve mid-single-digit operating profit growth and margin expansion target. Comments taken from Q4 earnings conference call.
|
UEPS | Hot Stocks09:37 EDT Net 1 UEPS reports agreement to acquire added 5% stake in Bank Frick - Net 1 UEPS Technologies announced that it has entered into an agreement to acquire a 5% additional interest in Bank Frick & Co., a fully licensed bank based in Balzers, Liechtenstein. Following the successful completion of this investment, the company will own 35% of Bank Frick. The company has an option, exercisable until October 2, 2019, to acquire an additional 35% interest in Bank Frick. "Our further investment in Bank Frick emphasizes the importance of our involvement with the Bank, and the multiple synergies between our two organizations. Bank Frick is progressive and has developed a range of exciting business models and products in the areas of payment, cryptocurrency trading and blockchain applications, and its pipeline of new products and services is growing. With blockchain in particular, we see interesting opportunities to make attractive products available for people in countries with a low concentration of banks," said Herman G. Kotze, CEO of Net1.
|
UPS | Hot Stocks09:34 EDT UPS announces new Worldwide Express Freight Midday service - UPS announced the introduction of UPS Worldwide Express Freight Midday, an extension of the current UPS Worldwide Express Freight service, offering a commit time of 12 p.m. or 2 p.m. from all 71 origin countries to 35 key destination countries that represent over two-thirds of global GDP. This addition to the UPS Worldwide Express package portfolio provides guaranteed, time-definite delivery for urgent, international palletized shipments over 150 lbs. Delivery is door-to-door in as few as 1-3 days, with customs brokerage included. UPS Worldwide Express Freight services include many of the same features as UPS Worldwide Express package service, allowing customers to leverage UPS speed, reliability, and visibility to reach global markets faster, now before end of day. Also new for 2018, UPS Worldwide Express Freight service has expanded to Lebanon, Latvia, and Lithuania and added outbound service to Saudi Arabia. UPS also announced expansion of the UPS Worldwide Express product to more than 7,000 postal codes in 57 countries. UPS Worldwide Express service offers guaranteed midday delivery (by 10:30 a.m., 12 p.m., or 2 p.m. depending on the destination) to 124 countries globally. It is a part of a portfolio of products that offer global express delivery in 1-3 days depending on the destination. UPS Express service offers guaranteed midday delivery, while Express Plus offers guaranteed morning delivery, and UPS Express Saver offers guaranteed end of day delivery, all with the same days in transit.
|
TWTR... | Hot Stocks09:25 EDT On The Fly: Pre-market Movers - UP AFTER EARNINGS: Twitter (TWTR), up 25.8%... Viacom (VIAB), up 3.24%... CVS Health (CVS), up 3.3%... Tyson Foods (TSN), up 4.9%... Yum! Brands (YUM), up just under 1% after reporting quarterly results and announcing a partnership with GrubHub (GRUB)... GrubHub is up 19.4%... Philip Morris (PM), up 2.1%... Kellogg (K), up 1.7%... Sally Beauty (SBH), up 8.4%... Coty (COTY), up 12.4%... Regeneron (REGN), up 2.8%... World Wrestling Entertainment (WWE), up 4.4%. DOWN AFTER EARNINGS: T-Mobile (TMUS), dpwn 1.6%... Yelp (YELP), down 8.8%... Take-Two (TTWO), down 2.7%... iRobot (IRBT), down 20.5%.
|
VIA... | Hot Stocks09:21 EDT Viacom: Fox, Disney deal increases value of Paramount Studios
|
VIA VIAB | Hot Stocks09:18 EDT Viacom CEO says will look at M&A, partnership opportunities
|
TYL | Hot Stocks09:17 EDT Tyler's Odyssey solution selected by state of Kansas in over $20M deal - Tyler Technologies signed an agreement with the Kansas Judicial Branch for a suite of Tyler's Odyssey solutions, including Odyssey Case Manager, Odyssey Financial Manager, Odyssey Supervision and Odyssey Judge Edition. The agreement, valued at more than $20M, was signed in the fourth quarter and includes project management, implementation consulting, training, and go-live assistance for a multitiered rollout plan throughout the state of Kansas, as well as long-term maintenance and support.
|
VIA... | Hot Stocks09:15 EDT Viacom CFO says in talks with wireless carriers on distribution deals
|
ICE | Hot Stocks09:09 EDT NYSE announces April 30 launch of NYSE National
|
INSE | Hot Stocks09:08 EDT Inspired Entertainment announces extended VLT order with OPAP - Inspired Entertainment will supply an additional 1,035 SBG VLTs to OPAP bringing its total number of contracted machines in Greece to 7,395. To date, Inspired has supplied 4,570 cabinets to OPAP, with over 3,600 machines now operating as part of OPAP's continued deployment of SBG VLTs into its retail network.
|
CVS AET | Hot Stocks09:08 EDT CVS Health says has begun planning for Aetna transaction - Says still expects the deal to close in 2H18.
|
GSK PFE | Hot Stocks09:07 EDT ViiV Healthcare announces phase 3 study of HIV two-drug regimen - ViiV Healthcare, the global specialist HIV company majority owned by GSK (GSK), with Pfizer (PFE) and Shionogi Limited as shareholders, announced the start of a phase III study designed to establish if adults with HIV-1 with current virologic suppression on a tenofovir alafenamide fumarate-based regimen of at least three drugs are able to maintain viral suppression upon switching to a two-drug regimen of dolutegravir and lamivudine. The TANGO study will seek to enrol approximately 550 adults with HIV-1, from clinical trial sites in North America, Europe, Australia, and Japan. The TANGO trial is designed to demonstrate the non-inferior antiviral activity of switching to dolutegravir and lamivudine compared to continuation of a TAF-based regimen over 48 weeks in virologically suppressed subjects. TANGO will characterise patient satisfaction as well as the long-term antiviral activity, tolerability and safety of a 2DR of dolutegravir and lamivudine through to 96 weeks.
|
VIA VIAB | Hot Stocks09:07 EDT Viacom says 'actively working' to address ratings softness at Nickelodeon
|
VIA VIAB | Hot Stocks09:07 EDT Viacom says there has been 'no change' in leadership at Nickelodeon - Says Sarah Levy has been to promoted to COO of Viacom Media Networks.
|
GSK... | Hot Stocks09:05 EDT GlaxoSmithKline, Pfizer venture files patent infringement litigation against Gilead - ViiV Healthcare, the global specialist HIV company majority-owned by GlaxoSmithKline (GSK), with Pfizer (PFE) and Shionogi Limited as shareholders, announced that it has filed patent infringement litigation against Gilead Sciences (GILD) over bictegravir in the United States and Canada. The United States case is filed in the U.S. District Court for the District of Delaware and the patent is U.S patent No. 8,129,385. The Canadian case is filed in the Canadian Federal Court in Toronto and the patent is Canadian Patent No. 2,606,282. ViiV Healthcare will seek to prove that Gilead Sciences' triple combination HIV drug containing the HIV integrase inhibitor bictegravir infringes ViiV Healthcare's patent covering ViiV Healthcare's dolutegravir and many other compounds that include dolutegravir's unique chemical scaffold. ViiV Healthcare said it will seek "financial redress" for the patent infringement.
|
KRA | Hot Stocks09:04 EDT Kraton increases capacity 20% for Sylvatraxx tread enhancement additives - Kraton intends to increase operational capacity of Sylvatraxx tread enhancement additives to meet the growing demand in the tire industry. Kraton anticipates that the expansion will result in a 20% increase in production at the Niort plant in France and is scheduled to complete by Q4. Kraton is exploring additional options for manufacturing expansion to meet long-term demand growth.
|
VIA VIAB | Hot Stocks09:03 EDT Viacom says to pursue opportunities to delever over 2019 - Expects Paramount to generate meaningful improvement to bottom line in FY18 vs. FY17.
|
SKYW | Hot Stocks09:03 EDT SkyWest raises quarterly dividend to 10c from 8c per share - Will be paid on April 5 to shareholders of record at the close of business on March 30.
|
SLCA | Hot Stocks09:02 EDT U.S. Silica increasing prices 4%-14% on industrial and specialty products - U.S. Silica's Industrial and Specialty Products business has increased prices for the majority of its non-contracted silica sand, cool roof granule, aplite and specialty products used primarily in glass, foundry, paints, coatings, elastomers, roofing, chemical, recreation, building products and other applications. The increases were effective for shipments after January 1. Price increases will range from 4% to 14%, depending on the product and grade. The price increases are being made to support the continued investment the company is making in upgrading its capacity to meet the growing demand for its products and to offset rising production costs.
|
GLYC | Hot Stocks09:02 EDT GlycoMimetics, HOVON enter agreement to initiatie trial startup activities - GlycoMimetics announced that it has entered into an agreement with the Haemato Oncology Foundation for Adults in the Netherlands group to initiate clinical trial startup activities. In the planned clinical trial, HOVON researchers will evaluate GlycoMimetics' drug candidate, GMI-1271, in adults with newly diagnosed acute myeloid leukemia but who cannot tolerate intensive chemotherapy, as well as in patients with myelodysplastic syndrome with a high risk of leukemia. The HOVON Central Office has already approved a protocol concept, and this agreement enables HOVON to commit staff to the planned trial in order to finalize the protocol, start regulatory and ethics reviews, and begin development of the database. Separately, GlycoMimetics said it plans to announce the design details for its company-sponsored Phase 3 trial in relapsed/refractory AML patients as part of its fourth-quarter and year-end 2017 earnings call scheduled for March 6, 2018. The HOVON trial will be the first to evaluate GMI-1271 together with decitabine in this underserved population of AML and MDS patients, who are not considered by their physicians to be candidates for intensive chemotherapy; these two populations represent a significant potential label expansion opportunity for GMI-1271. HOVON intends to enroll approximately 140 patients in the clinical trial, including a control arm. Key efficacy endpoints will include complete remission rate, disease-free survival, and overall survival. The trial is expected to start this year and will be conducted in five countries across Europe.
|
XOM | Hot Stocks09:00 EDT Exxon Mobil says added 2.7B barrels to reserves in 2017 - Exxon Mobil said it added 2.7 billion oil-equivalent barrels of proved oil and gas reserves in 2017, replacing 183 percent of production. ExxonMobil's proved reserves totaled 21.2 billion oil-equivalent barrels at year-end 2017. Liquids represented 57 percent of the reserves, up from 53 percent in 2016. ExxonMobil's reserves life at current production rates is 14 years. "Our exploration success and strategic acquisitions made during a period of low commodity prices are adding high-quality resources that are among the lowest cost of supply in the industry," said Darren W. Woods, chairman and CEO. "ExxonMobil's portfolio of development opportunities positions us to grow shareholder value as we bring on new supplies of oil and natural gas to meet growing demand." During 2017, proved additions at Upper Zakum in Abu Dhabi totaled more than 800 million barrels of crude oil. Additions from liquids-rich unconventional plays in the United States, mainly in the Permian Basin, totaled approximately 800 million oil-equivalent barrels. Additions in the Permian are supported by ExxonMobil's growth plan and increased drilling activity, expected to increase daily production to more than 600,000 oil-equivalent barrels by 2025. Other significant new proved reserve additions were made in Guyana, where the company funded the first phase of development last year, and in Mozambique, associated with the project funding of the Coral FLNG project in the gas-rich deepwater Area 4.
|
ABUS | Hot Stocks09:00 EDT Arbutus Biopharma trading resumes
|
VIA VIAB | Hot Stocks08:59 EDT Viacom CFO says company to be 'significant beneficiary' of U.S. tax reform - Expects domestic affiliate revenues in March, June quarters to decline in line with last year. Sees September quarter domestic affiliate revenues to decline in low single digits. Says International pacing ahead of original plans. Says company to be "significant beneficiary" of U.S. tax reform.
|
CVS | Hot Stocks08:57 EDT CVS Health says lower tax rate a 'recurring benefit' to business
|
VIA VIAB | Hot Stocks08:49 EDT Viacom sees growing operating income for Telefe by 40% this year
|
ABUS | Hot Stocks08:49 EDT Arbutus Biopharma to reduce workforce by approximately 31 % in restructuring - Arbutus Biopharma announced a site consolidation and organizational restructuring to better align its HBV business in Warminster, PA. These organizational changes are expected to result in increased efficiency, a more flexible variable cost structure, and additional preservation of the Company's cash reserves. The company's Lipid Nanoparticle technology group will remain intact. To achieve this alignment, Arbutus will reduce its global workforce by approximately 31% and plans to close its Burnaby facility. The company will incur restructuring costs related to one-time employee termination benefits, employee relocation costs, and site closure costs currently estimated to be $5.0M, which will be primarily paid in cash in the second quarter of 2018. "We have chosen to consolidate our business around Warminster PA, the center of our HBV discovery activities, thereby maximizing our focus on our mission to cure chronic HBV. As a result, some very talented and committed people will leave our organization and we thank them for their efforts. Arbutus has a broad pipeline of HBV assets and a strong balance sheet and we are committed to leading the field to an HBV cure," said CEO Mark Murray.
|
MARA | Hot Stocks08:47 EDT Marathon Patent Group announces purchase of 1,400 Bitmain Antminer S9s - Marathon Patent Group announced that the company has purchased 1,400 of Bitmain's Antminer S9 miners. These 1,400 miners are in addition to the previously announced 1,300 Antminer S9s purchased by Global Bit Ventures, Inc. on January 12, 2018 and the 1,000 GPU mining servers which GBV already owns. Once fully deployed, the combined 2,700 Bitmain S9 miners are expected to produce approximately 33 Ph/s of ASIC mining capacity in addition to the 1,000 GPU mining servers owned by GBV which are capable of 250 Gh/s. Merrick Okamoto, Marathon's Interim CEO and Chairman of the Board of Directors, stated, "We are continuing to execute on our plan to rapidly grow our mining capacity and revenue."
|
VIA VIAB | Hot Stocks08:47 EDT Viacom CEO: Spongebob musical 'off to a very good start'
|
RESN | Hot Stocks08:46 EDT Resonant expands relationship with Tier 1 customer - Resonant announced it has signed an extension to a licensing agreement with an existing Tier 1 filter customer. The expanded licensing agreement, which follows the Tier 1's continued traction with phone OEMs, covers the addition of two high-value duplexers. The designs, which leverage Resonant's Infinite Synthesized Network software platform, are high average sales price, high-volume duplexers which are being designed in temperature compensated surface acoustic wave. Upfront payments and licensing terms have been agreed upon, but will not be disclosed due to the confidential nature of such agreements.
|
AMRS | Hot Stocks08:46 EDT Amyris joint venture launches pharmaceutical grade Neossance Squalane USP - Amyris announced that Aprinnova, its joint venture with NIKKOL, has launched pharmaceutical grade Neossance Squalane USP. "This new material meets the industry standards required by the United States Pharmacopeia and the National Formulary for drug actives and pharmaceutical excipients, which are used by regulatory agencies and manufacturers to ensure products have the appropriate identity, quality, purity, and consistency. As a result, Aprinnova is now able to supply these industries with FDA-regulated sugarcane-derived squalane, which was previously unavailable to these markets since shark-derived squalane was the only source reference in the regulatory monograph for squalene," the company stated.
|
SWN | Hot Stocks08:43 EDT Southwestern Energy trading resumes
|
STRM | Hot Stocks08:43 EDT Streamline Health's Health eValuator adds heathcare customer - Streamline Health signed a new agreement on January 31 with another Midwestern healthcare provider. The new client contracted for Streamline Health eValuator, the new cloud-based automated pre-bill code analysis technology, as well as both pre-bill and post-bill Auditing Services. By improving coding accuracy before billing, providers can reduce revenue leakage, mitigate overbill risk, and reduce denials and days in A/R.
|
TWTR | Hot Stocks08:42 EDT Twitter says 'no update today' on plans to monetize TweetDeck - The company is "looking at opportunities" there, but has no update today on TweetDeck, Twitter CEO Jack Dorsey said.
|
VIA VIAB | Hot Stocks08:42 EDT Viacom CEO says company has reached 'turning point' in domestic ad. story - Viacom (VIA, VIAB) said on its Q4 earnings conference call that it will not comment on the ongoing process with CBS (CBS, CBS.A). CEO Bob Bakish said 2018 is about transforming company for the future. He said that early results of the Paramount Network are "encouraging," noting that the network had 12.1M viewers in its launch week. Bakish expects FY domestic affiliate revenue to decline at the low end of low single digits. He sees a "turning point" in domestic advertising story, and sees domestic ad revenue improving sequentially over balance of year, with positive growth in Q4. Bakish said that the turnaround for Paramount Pictures is "well in sight." Bakish also noted that Paramount Pictures is expanding TV production relationships and that George Clooney will direct and start in CATCH-22, a limited series for Hulu. Bakish expects its initiatives to deliver $100M in cost savings this year and generate hundreds of millions of savings on an annual run rate basis. Comments taken from the Q4 earnings conference call.
|
RIOT | Hot Stocks08:41 EDT Riot Blockchain invests additional C$3.4M in Coinsquare - Riot Blockchain has invested an additional C$3.4M in one of its portfolio holdings, goNumerical, dba "Coinsquare". The investment is part of a C$30M financing at a C$430M post-money valuation. This valuation for Coinsquare is over fifteen times the valuation from Riot Blockchain's initial investment in September 2017. Riot Blockchain additionally exercised its previously acquired warrants at a C$94M valuation, and now owns approximately 12.5% of Coinsquare after the latest investment.
|
CVS AET | Hot Stocks08:39 EDT CVS Health says FY18 share repurchases suspended due to Aetna transaction - Expect to use cash to pay down existing debt, continue to pay $2 per share annual dividend and fund purchase of Aetna (AET).
|
CELH | Hot Stocks08:38 EDT Celsius Holdings expands product distribution in Scandinavia - Celsius Holdings has begun distribution of its product line in Norway through its Nordic distribution partner, Func Food. Additionally, this March, Celsius will be introducing a branch-chained amino acids drink to the Finland and Sweden markets. In early January, under the CELSIUS brand name, Nordic distribution partner Func Foods launched five flavors to select fitness channel customers in Norway. Plans are to expand the distribution to other select channels of trade including online, specialty, convenience and grocery.
|
SGBX | Hot Stocks08:38 EDT SG Blocks wins contract to design, construct workforce housing development - SG Block has secured a major workforce housing project in Sullivan County, New York, representing the second largest project in company history. SG Blocks has been commissioned to design and build a four-building, 183,000-square foot multi-story, multi-family workforce housing development in Sullivan County, New York, representing an estimated revenue opportunity of $29 million. This complex will be built to house low- to middle-income households. SG Blocks will provide the services of a turn-key development manager for this project, including architectural engineering and design, project administration and building systems work. The workforce housing development will target employees for a newly built $1.2N destination resort that includes: an 18-story hotel and a casino and entertainment complex with approximately 100,000 square feet of casino floor, an entertainment village, golf course and waterpark. The hotel and casino will feature more than 10 varied bar and restaurant experiences, including fine dining and an Italian steakhouse created by celebrity chef Scott Conant, and year-round live entertainment at the 2,500-seat event center. .
|
WMT SQ | Hot Stocks08:37 EDT Walmart names Square CFO Sarah Friar to board - Walmart (WMT) announced that its board of directors has appointed Sarah Friar, CFO of Square (SQ), as a new independent director to the company's board, effective immediately. Friar becomes the twelfth member of the board and will also serve as a member of the company's Audit Committee and Strategic Planning and Finance Committee.
|
SWN | Hot Stocks08:36 EDT Southwestern Energy sees 2018 average net production up 6% to 930-965 Bcfe - Sees 2018 CapEx $1.15B-$1.25B. Sees Appalachian Basin net production of 671 to 698 Bcfe, an 18% increase over 2017, including a 30% increase in Southwest Appalachia; NGLs and condensate production increase to approximately 130 Bcfe, an increase of 31% compared to 2017; expects Northeast Appalachia to generate positive cash flow from operations, net of capital for the first time, delivering approximately $150M; total Company and Northeast Appalachia gas differentials expected to improve by approximately 10c per Mcf and 25c per Mcf, respectively; and hedge protection on approximately 69% of projected 2018 natural gas volumes at an average swap or purchased put strike price of $2.97 per Mcf.
|
WWE | Hot Stocks08:35 EDT WWE promotes George Barrios, Michelle Wilson to co-presidents - In recognition of their contributions to four years of record revenues and the successful transformation to a multiplatform business model, WWE Chairman & CEO Vince McMahon announced that George Barrios and Michelle Wilson have been promoted to Co-Presidents and appointed to WWE's Board of Directors. Barrios and Wilson will continue to report directly to McMahon.
|
WWE | Hot Stocks08:35 EDT WWE sees FY18 adjusted OIBDA at least $140M - In 2018, management expects the Company to achieve another year of record revenue and previously targeted Adjusted OIBDA of at least $115 million, which would represent another all-time record. Based on the Company's revised definition of Adjusted OIBDA, which excludes projected stock compensation expense, this equates to an approximate 2018 Adjusted OIBDA target of at least $140 million.
|
WWE | Hot Stocks08:34 EDT WWE sees Q1 adjusted OIBDA $23M-$27M - The Company evaluates the operating performance of its segments based on financial measures such as revenue, OIBDA and Adjusted OIBDA. To further facilitate the analysis of the Company's operating performance, the Company plans to change its primary measure of performance from OIBDA to Adjusted OIBDA, and to modify its definition of Adjusted OIBDA to exclude stock-based compensation expense. The Company plans to begin reporting results using this revised definition with the communication of first quarter 2018 results In early 2017, management discussed a step-up in capital expenditures to expand the Company's overall production capacity. The related spending to retrofit a recently purchased facility was largely delayed until 2018 as plans were finalized. For 2018, the Company anticipates capital expenditures of $50 million to $70 million, reflecting in part the shift in spending from 2017.
|
NYT | Hot Stocks08:33 EDT New York Times sees FY18 CapEx $60M-$70M - Total subscription revenues in the first quarter of 2018 are expected to increase in the mid to high-single digits compared to the first quarter of 2017. Total advertising revenues in the first quarter of 2018 are expected to decrease in the mid to high-single digits compared with the first quarter of 2017. Operating costs and adjusted operating costs are expected to increase in the low-single digits in the first quarter of 2018 compared with the first quarter of 2017. The company expects the following on a pre-tax basis in 2018: Depreciation and amortization: $60 million to $65 million, Interest expense, net: $18 million to $21 million, and Capital expenditures: $60 million to $70 million.
|
WWE | Hot Stocks08:33 EDT WWE: Certain distribution agreements to expire in 2019 - The monetization of WWE content is a fundamental element of the company's business model. Certain distribution agreements that represent a significant share of the company's television rights revenue will expire in 2019. These agreements include the licensing of WWE's premier programs, Raw and SmackDown, in the U.S., which will expire on September 30, 2019, as well as in the U.K. and India, which will expire on December 31, 2019. Management currently expects to announce its plan for future distribution in the U.S. sometime between May 2018 and September 2018; for future distribution in the U.K. by year-end 2018; and for future distribution in India in the first half of 2019. Although these announcements could occur either before or after these dates, management believes that these ranges represent the most likely periods for such communication.
|
ABUS | Hot Stocks08:30 EDT Arbutus Biopharma trading halted, news dissemination
|
TWTR | Hot Stocks08:28 EDT Twitter CFO says no change to thinking on capital use, 'nothing to report there'
|
TMUS | Hot Stocks08:27 EDT T-Mobile says 'race is on' for 5G
|
TWTR | Hot Stocks08:27 EDT Twitter CFO 'feels good' about where company is on user time spent
|
ATNM | Hot Stocks08:26 EDT Actinium Pharmaceuticals appoints Anil Kapur as Chief Commercial Officer - Actinium Pharmaceuticals announced, effective today, that Anil Kapur has been appointed Chief Commercial Officer. Anil will be responsible for building the commercial capabilities at Actinium in anticipation of launching Iomab-B and Actimab-MDS, the Company's current programs that are intended to improve bone marrow transplant access and outcomes through improved myeloablation.
|
SNCR | Hot Stocks08:26 EDT Synchronoss says receives positive Nasdaq panel decision - Synchronoss Technologies announced that it received a positive decision from the Nasdaq Hearings Panel, which granted the company an extension to regain compliance with Nasdaq's listing requirements. Under the extension, the company's common stock will remain listed on the Nasdaq Stock Market, subject to the company becoming current with its SEC filings on or before May 10, 2018. The extension is also subject to the company providing the Panel with periodic updates regarding its ongoing restatement of its financial statements and an investor update on or before March 31, 2018.
|
NLSN | Hot Stocks08:25 EDT Nielsen says on track to be 'currency for digital viewing' - Says Watch segment is delivering on initiatives and driving growth. Says growth and momentum remains strong. Continues to see solid growth from both local and multinational customers in Buy segment. Anticipates U.S. tax reform to result in FY18 tax rate of 32%-34%. Expects to re-invest tax benefits to boost growth and profitability. Says expanding viewing captured by the C3/C7 currency. Says on track to be currency for digital viewing. Says investing in growth opportunities in Watch segment. Says focused on investing in growth in the Buy segment despite current environment. Says growing connected partner program, covering faster growing channels. Comments taken from Q4 earnings conference call.
|
TEVA | Hot Stocks08:25 EDT Teva says expects Q1 to be 'strongest of the year'
|
TEVA | Hot Stocks08:24 EDT Teva sees FY18 CapEx approximately $700M
|
TEVA | Hot Stocks08:23 EDT Teva says expects FY18 tax rate 17%-19%
|
RNN | Hot Stocks08:22 EDT Rexahn announces collaboration with Zhejiang Haichang Biotechnology - Rexahn Pharmaceuticals announced that it has entered into a collaboration and license agreement with Zhejiang Haichang Biotechnology, to develop RX-02 for the treatment of hepatocellular carcinoma, or HCC, the most common form of liver cancer. Under the terms of the agreement, Haichang will develop a nano-liposomal formulation of RX-0201 using its proprietary QTsome technology and conduct certain pre-clinical and clinical activities through completion of a Phase IIa proof-of-concept clinical trial for the treatment of HCC. Any clinical trials conducted by Haichang will be designed to meet both U.S. and Chinese regulatory requirements. Haichang will fund all research and development activities through completion of the Phase IIa clinical trial. The parties will share in an agreed ratio downstream licensing fees and royalties paid by third parties in connection with the further development and commercialization of the nano-liposomal formulation of RX-0201 for the treatment of HCC.
|
TEVA | Hot Stocks08:22 EDT Teva says sees FY18 global Copaxone sales of approximately $1.8B
|
SWN | Hot Stocks08:21 EDT Southwestern Energy trading halted, news pending
|
TWTR | Hot Stocks08:20 EDT Twitter CFO, asked about DAU disclosures, says 'high bar' for making changes - Responding to a question about whether the company plans to make a change and begin disclosing a precise DAU figure beyond just a percentage change, Twitter CFO Ned Segal said the company "carefully weigh[s] what we share" and "we have a high bar for making changes and an even higher bar for making changes inside of the year to make sure that you all are able to compare things from one period to another." Segal said the absolute number of MAU gives a sense for a number that's higher up in the funnel and "giving you the percentage growth for DAU gives you a sense for our trajectory in driving usage of Twitter as a daily utility...and so we'll continue to do that."
|
TEVA | Hot Stocks08:19 EDT Teva says expects to use 'bulk' of free cash flow to reduce debt in FY18
|
TMUS | Hot Stocks08:16 EDT T-Mobile CFO sees FY18 ARPU 'generally stable' with FY17
|
TMUS | Hot Stocks08:15 EDT T-Mobile CFO says company doesn't expect to pay material cash taxes until 2024
|
TEVA | Hot Stocks08:14 EDT Teva says Copaxone generic accounts for half of sales forecast fall
|
TMUS | Hot Stocks08:13 EDT T-Mobile CFO: Tax reform to be 'very beneficial' to company
|
TMUS | Hot Stocks08:13 EDT T-Mobile CEO: 90% of cell sites in Puerto Rico have been restored - T-Mobile CEO John Legere says the company remains the "only growth company in U.S. wireless." Says that while Puerto Rico "still has a long way to go," recovery has been "particularly hard," Legere says 90% of cell sites in Puerto Rico have been restored. Says has bought back 12.3M shares for $783M since share repurchase program was initiated in December. Says has captured over 1M net adds for 19 quarters in a row. Expects 2018 to be T-Mobile's "best year yet" and that 2017 was "only the beginning" of expansion efforts. Legere says T-Mobile will focus on expanding in areas where the carrier hasn't traditionally been. Says the Layer3 TV acquisition represents a progression in video strategy. Says believes content is moving to the internet and the internet is "going mobile." Sees opportunity to improve presence in enterprise, where it currently has only a 2%-3% market share. Comments taken from the Q4 earnings conference call.
|
OPNT | Hot Stocks08:12 EDT Opiant Pharmaceuticals to record about $11.7M in royalty, milestone payments - Opiant Pharmaceuticals announced that it will record a total of approximately $11.7 million in royalty and milestone payments for the five-month transition period ended December 31, 2017, as a result of a change in year-end from July 31 to December 31. The royalty and milestone payments relate to full-year 2017 sales of NARCAN Nasal Spray for opioid overdose by the Opiant's commercial partner, Adapt Pharma Operations Limited. The approximately $11.7 million of revenue to be recognized follows Opiant's recent disclosure that, going forward, it would receive 90% of royalty and milestone payments related to NARCAN sales directly from Adapt Pharma, with its obligations to SWK Funding LLC being correspondingly reduced to 10%, as SWK will have been repaid its investment and return on investment per the terms of the royalty monetization agreement between the parties.
|
TEVA | Hot Stocks08:12 EDT Teva says won't be able to keep same pace of debt repayment - Says has repaid $1.1B in debt this year. Comments from Q4 earnings conference call.
|
CBI | Hot Stocks08:12 EDT CB&I awarded contract in UAE for crude flexibility project - CB&I has received a letter of award from Abu Dhabi National Oil Company, the national oil company of United Arab Emirates and the parent company of ADNOC Refining, to build a Crude Flexibility Project valued at more than $500M in Ruwais, UAE. CB&I is part of a joint venture led by Samsung Engineering that will execute the $3.1B CFP, which will upgrade the Ruwais Refinery to process heavier offshore crude oil from Upper Zakum fields. Approximately 40% of the value of the project is expected to be spent in the UAE supply chain.
|
VSAT UAL | Hot Stocks08:10 EDT ViaSat to provide connectivity to new United Continental aircraft - Viasat (VSAT) signed a new contract with United Airlines (UAL) to bring Viasat's in-flight entertainment and connectivity system to more than 70 aircraft, including at least 58 of United's new Boeing 737MAX aircraft. Viasat will serve as the direct in-flight internet service provider to United. Viasat's IFEC system will also power United's Private Screening entertainment option.
|
K | Hot Stocks08:09 EDT Kellogg CEO says 'We enter 2018 on sound financial footing' - "We enter 2018 on sound financial footing, with many of our businesses starting to gain traction," added CEO Cahillane." "Net sales guidance for 2018 reflects roughly two quarters of negative DSD-transition impacts and the prudent assumption that it will take some time for our investments to take hold. Our commercial ideas are stronger and we are putting increased investment where the growth is. We have strong enough cost-savings that we can boost investment in growth, while still delivering margin expansion and solid growth in profit and earnings."
|
BEL | Hot Stocks08:08 EDT Belmond acquires Tuscan resort Castello Di Casole for EUR39M - Belmond announced that it has acquired Castello di Casole, a luxury resort and estate in Tuscany, Italy. The company purchased from the current owner the entire equity capital of two entities that together own Castello di Casole, one of the largest private real estate properties in Tuscany. The purchase price, including transaction costs, is approximately EUR39M, or $48M, with a possible further EUR2.85M, or $3.5M, payable contingent upon certain real estate sales being realized. The property is the latest addition to Belmond's family of 'Italian Icons', which includes Belmond Hotel Cipriani in Venice and Belmond Hotel Splendido in Portofino.The acquisition has been financed using cash on hand. Upon takeover of management, Belmond will rebrand the resort as Belmond Castello di Casole. Starting in 2018, the Company expects to invest EUR7.3M, or $9M, in a phased refurbishment of the hotel over four years, including the addition of two new villas on two residential plots that will be retained, bringing the resort's total key count to 41. In addition, the Company expects to sell the remaining 14 land plots, including the three that are subject to reservation letters, over the coming years, effectively reducing the Company's net investment in the estate.
|
DRIO | Hot Stocks08:08 EDT DarioHealth's Dario glucose monitoring system included in clinical study - DarioHealth has entered into an agreement with a pharmaceutical company conducting a clinical study for a new drug related to managing diabetes. The pharmaceutical company is seeking FDA clearance for this drug and has selected DarioHealth to run and track the blood glucose readings of participants in the clinical study. DarioHealth's B2B platform aims to increase user engagement during the course of the clinical study.
|
TWTR | Hot Stocks08:06 EDT Twitter CEO sees expenses to 'more closely align with revenue' - Twitter CEO Jack Dorsey is speaking on the company's Q4 earnings call.
|
K | Hot Stocks08:05 EDT Kellogg sees FY18 cash flow from operating activities $1.7B-$1.8B
|
AUPH RGLS | Hot Stocks08:05 EDT Aurinia Pharmaceuticals names Regulus CEO Joseph Hagan to board - Aurinia Pharmaceuticals (AUPH) announced the appointment of Joseph P. "Jay" Hagan. to its board of directors. Hagan is currently the President and CEO of Regulus Therapeutics (RGLS).
|
TEUM | Hot Stocks08:04 EDT Pareteum granted patent for cloud security solution - Pareteum's European operating subsidiary has been granted a UK patent for a solution enabling strong-authentication, which provides secure access and additional identity validation on Pareteum's Global Cloud Platform and other online services. The technology uses pre-shared secret key authentication between mobile devices and secure cloud services, such as Pareteum's Global Cloud Platform.
|
ALNY | Hot Stocks08:04 EDT Alnylam sees FY18 non-GAAP R&D expenses $400M-$440M - Alnylam expects that its cash, cash equivalents and fixed income marketable securities, restricted cash and restricted investments balance will be approximately $1B at December 31, 2018. The company expects its 2018 annual Non-GAAP R&D expenses to be in the range of $400M to $440M and Non-GAAP selling, general and administrative expenses to be in the range of $280M to $320M. Both Non-GAAP R&D and SG&A expenses exclude stock-based compensation expenses.
|
CTB | Hot Stocks08:03 EDT Cooper Tire announces offtake agreement with Sailun Vietnam - Cooper Tire & Rubber Company announced it has entered into a multi-year manufacturing offtake agreement with Sailun Vietnam Co., Ltd. for the production of Truck and Bus Radial tires for global markets. The offtake agreement gives Cooper a third global source of TBR tire production to meet growing customer needs. Tires will be manufactured under the Roadmaster, Dean and Starfire brands.
|
FAT | Hot Stocks08:02 EDT Fat Brands announces initiation of 12c quarterly cash dividend - FAT Brands announced that its Board of Directors has approved its first quarterly cash dividend. The company's Board of Directors declared an initial quarterly dividend of 12c per share of common stock, payable on April 16, 2018 to stockholders of record as of the close of business on March 30, 2018.
|
BAESY LMT | Hot Stocks08:01 EDT BAE Systems to modernize head-up displays for UAE F-16 fleet - BAE Systems (BAESY) has been selected by Lockheed Martin (LMT) to modernize head-up displays on F-16 aircraft for the United Arab Emirates Armed Forces, replacing the fleet's analog system with advanced digital technology. The HUD, which sits directly in a pilot's line of sight, is a see-through display that presents real-time, flight-critical information without obstructing his or her view of the outside world.
|
GLUU DIS | Hot Stocks08:01 EDT Glu Mobile collaborates with Disney on mobile game - Glu Mobile (GLUU) announced it is collaborating with Disney Consumer Products and Interactive Media (DIS) on the development of an upcoming mobile game. The game is expected to include characters and stories from across Disney and Pixar franchises. Currently in early stages of development, the new title is the first to be led by Glu Senior Vice President and Creative Leader Mike Olsen. The upcoming free-to-play mobile title will be available worldwide on the App Store and Google Play.
|
TSN | Hot Stocks07:37 EDT Tyson Foods says over $100M in one-time cash bonuses to be paid - Tyson sees incremental tax reform cash flow in fiscal 2018 to exceed $300M, which the company intend to invest in frontline team members and to "sustainably grow our businesses. Tyson said more than $100M in one-time cash bonuses to be paid to eligible frontline employees in the second quarter of fiscal 2018.
|
QCOM | Hot Stocks07:37 EDT Qualcomm's Snapdragon X50 5G modem selected for mobile 5G NR trials - Qualcomm Technologies, a subsidiary of Qualcomm Incorporated, announced that its Qualcomm Snapdragon X50 5G modem has been selected for use in live, over-the-air mobile 5G NR trials with multiple global wireless network operators in both the sub-6 GHz and millimeter wave spectrum bands. AT&T, British Telecom, China Telecom, China Mobile, China Unicom, Deutsche Telekom, KDDI, KT Corporation, LG Uplus, NTT DOCOMO, Orange, Singtel, SK Telecom, Sprint, Telstra, TIM, Verizon and Vodafone Group will conduct the trials, which will be based on the 3GPP Release 15 5G NR standard. The mobile 5G NR trials will utilize Qualcomm Technologies' 5G mobile test platform and smartphone reference design, which incorporate the Snapdragon X50 chipset and optimize 5G technology within the power and form factor constraints of a smartphone while maintaining interoperability and coexistence with 4G LTE. The planned trials underscore the readiness of Qualcomm Technologies' mobile 5G NR solution in a smartphone form factor and aim to commercialize standard-compliant 5G NR products and services over the coming year.
|
QCOM | Hot Stocks07:35 EDT Qualcomm's Snapdragon X50 5G NR modem family selected by global OEMs - Qualcomm Technologies, a subsidiary of Qualcomm Incorporated, announced that its Qualcomm Snapdragon X50 5G NR modem family has been selected by a number of global original equipment manufacturers for standard-compliant 5G NR mobile device product launches starting in 2019. Those working with Qualcomm Technologies include OEMs such as Asus, Fujitsu Limited, Fujitsu Connected Technologies Limited, HMD Global - the home of Nokia phones, HTC, Inseego/Novatel Wireless, LG, NetComm Wireless, NETGEAR, OPPO, Sharp Corporation, Sierra Wireless, Sony Mobile, Telit, vivo, Wingtech, WNC, Xiaomi and ZTE. These OEMs are working to commercialize 5G mobile devices for the sub-6 GHz and millimeter wave spectrum bands starting in 2019 based on the first commercially announced 5G modem solution, the Snapdragon X50 5G NR modem family.
|
SEII | Hot Stocks07:34 EDT Sharing Economy International signs potential Pandoodle acquisition agreement - Sharing Economy International's wholly-owned subsidiary, EC Technology & Innovations, has entered into an exclusivity agreement with the shareholders of Pandoodle, regarding a potential acquisition by ECTI of not less than 51% of Pandoodle. Pandoodle provides video and imaging solutions that increase advertising value through artificial intelligence, video and image analysis and recognition technologies. Pandoodle offers Dolo, a Software-as-a-Service platform that automates the analysis and insertion of branded content, providing advertisers and publishers with personalized branding in real-time.
|
HBI | Hot Stocks07:33 EDT Hanesbrands to acquire Bras N Things for approximately $400M on enterprise basis - Hanes has entered into a definitive agreement to acquire Bras N Things, a specialty retailer and online seller of intimate apparel in Australia, New Zealand and South Africa. In 2017, Bras N Things had net sales of approximately A$180M. The all-cash transaction is valued at A$500M, or approximately $400M, on an enterprise-value basis. The purchase price is approximately 10 times 2017 EBITDA and is expected to be less than 8 times EBITDA after cost and revenue synergies. The pending acquisition is expected to be accretive to earnings in 2018.
|
WSO | Hot Stocks07:33 EDT Watsco raises annual dividend by 16% to $5.80 per share - Watsco announced that its board has approved a 16% increase in its annual dividend to $5.80 per share on each outstanding share of its Common and Class B common stock. The increase will be reflected in the company's next regular dividend payment beginning in April 2018.
|
MYND | Hot Stocks07:31 EDT MYnd Analytics awarded Canadian patent on neuromodulation platform - MYnd Analytics announced it has received its first notice of patent allowance in Canada on the company's neuromodulation platform for predicting patients likely to respond to Transcranial Magnetic Stimulation, or TMS. The patent is entitled "Method for Assessing the Susceptibility of a Human Individual Suffering from a Psychiatric or Neurological Disorder to Neuromodulation Treatment," and provides patent protection through 2029. The company has also applied for patents in the United States, which it expects will be awarded later this year. TMS is a non-invasive outpatient procedure that uses magnetic fields to stimulate areas of the brain thought to control mood. TMS is approved by the FDA as well as Health Canada, and is offered by psychiatrists throughout North America. TMS is used as an alternative treatment for patients who have failed one or more antidepressants for the treatment of depression.
|
ITG | Hot Stocks07:20 EDT ITG reports January U.S. trading volume 2.8B shares - ITG announced January 2018 U.S. trading volume of 2.8B shares and average daily volume or ADV was 132M shares, vs. 2.7B shares and ADV of 133M shares in December 2017 and 2.8B shares and ADV of 139M shares in January 2017. There were 21 trading days in January 2018 and 20 trading days in both December 2017 and January 2017.
|
CVS | Hot Stocks07:20 EDT CVS Health to increase wages, expand employee benefits - In a continuing commitment to investing in the growth and success of its employees, CVS Health announced three major programs that will enable employees to share in the tax savings created by the U.S. Tax Cuts and Jobs Act. The improvements in employee wages and benefits, which are long-term and sustainable compensation investments, total $425M annually and create continued growth opportunities for the company and its employees. The programs announced today include the following employee-focused investments: CVS Health will increase the starting wage rate for hourly employees to $11 an hour, effective April 2018. As part of this change, the company also plans to adjust pay ranges and rates for many of its retail pharmacy technicians, front store associates and other hourly retail employees later in the year to ensure a competitive compensation structure that supports the company's plans to evolve its retail stores into a health care destination. As part of ensuring access to affordable health care, CVS Health will not increase employee premiums for the 2018-2019 plan year. While medical and prescription costs have increased 5% year-over-year, CVS Health will absorb the entire increase for the 100,000 employees who have elected to enroll in the company-sponsored health plan. The company is also creating a new paid parental leave program. Effective April 1, 2018, full-time employees who welcome a new child into their home can take up to four weeks away from work at 100% of their pay to ensure the newest addition to their family gets off to a strong start in life. As part of the company's fourth quarter 2017 earnings announcement this morning, CVS Health indicated that it anticipated spending the remaining tax benefit on investments in data analytics, care management solutions and store service offering pilots to improve health outcomes and lower costs for patients, as well as on debt reduction related to its planned acquisition of Aetna.
|
GT | Hot Stocks07:18 EDT Goodyear Tire CEO says 'positive momentum as we head into 2018' - "Our fourth-quarter results were highlighted by our performance in the 17-inch-and-larger segment in consumer replacement, which delivered nearly double the industry growth in the U.S. and Europe," said Richard Kramer, chairman, CEO and president. "Our strong volume recovery in the quarter gives us positive momentum as we head into 2018." "These results reflect the power of the Goodyear brand across all of our regions," Kramer added. "Our strong global brand is integral to Goodyear's connected business model which combines innovation and technology leadership, industry-leading products, aligned wholesale and retail distribution and provides us with a competitive advantage. Looking ahead to 2020, I am very confident in our capability to execute our long-term strategy to capture profitable growth in key market segments and deliver significant growth in earnings," he added.
|
ACN | Hot Stocks07:18 EDT Accenture wins contract from U.S. Department of Veterans Affairs - Accenture has been awarded a contract by the U.S. Department of Veterans Affairs to modernize and enhance the existing loan oversight system for its Office of Information & Technology. The VA Loan Electronic Reporting Interface Redesign task order, managed by the Veterans Benefits Administration Loan Guaranty Division, has an estimated value of $16.3M over a base performance period of 18 months. The work done under VALERI-R will improve oversight capability over VA's loan systems, increase security and reduce the costs to service and liquidate VA-guaranteed loans at the VBA. The VALERI-R task order has four optional tasks that may be exercised at the Government's discretion during the option exercise period, which has a 54-month period commencing on the date of task order award. The overall period of performance shall not exceed 57 months, with a total value of $29M.
|
GT | Hot Stocks07:16 EDT Goodyear Tire sees FY18 segment operating income $1.8B-$1.9B - The company expects its full-year 2018 segment operating income to be between $1.8 and $1.9 billion. The company also has updated its 2020 segment operating income target and capital allocation plan: Segment operating income target in 2020 of $2.0 to $2.4 billion. The company's capital allocation plan includes growth capital, restructuring, debt/pension payments and a shareholder return program.
|
LB | Hot Stocks07:16 EDT L Brands reports January comparable sales up 7% - L Brands reported net sales of $1.040B for the five-week period ended Feb. 3, 2018, compared to sales of $805.2M for the four-week period ended Jan. 28, 2017. The fifth week in January 2018 represented approximately $150M in sales and 7c in earnings per share. The company reported comparable sales for the five weeks ended Feb. 3, 2018, increased 7% compared to the five weeks ended Feb. 4, 2017.
|
GKOS | Hot Stocks07:15 EDT Glaukos: iStent reduced IOP, lowered medication burden in patients, study says - Glaukos Corporation announced that a study published in the January 2018 issue of the Journal of Glaucoma showed that a single iStent Trabecular Micro-Bypass Stent implanted during cataract surgery in patients with severe open-angle glaucoma achieved mean postoperative intraocular pressure of 14.1 mm Hg and a 28% reduction in the mean number of glaucoma medications used after 36 months of follow-up. The retrospective case series included 59 glaucomatous eyes with cataracts and severe visual field loss. At baseline, the medicated mean IOP was 19.3 mm Hg and the mean number of topical glaucoma medications used per eye was 2.3. In 49 eyes followed for 24 months after iStent implantation and concomitant cataract surgery, mean postoperative IOP decreased to 14.9 mm Hg while the mean number of glaucoma medications used per eye declined to 1.6. In a consistent cohort of 32 eyes with available data through three years postoperative, the IOP reduction was maintained. At three years, this cohort achieved a mean postoperative IOP of 14.1 mm Hg, from a baseline mean medicated IOP of 18.1 mm Hg, and a 28% reduction in mean glaucoma medications used per eye from 2.44 preoperatively to 1.75. "While many prior studies have documented the clinical benefits of combining iStent implantation with cataract surgery in glaucoma patients who are in the mild to moderate stage of the disease, we believe this is the first published study to focus on its use in severe glaucoma patients undergoing cataract surgery," said John Berdahl MD, a South Dakota-based ophthalmic surgeon and one of the article's authors. "Our study showed that severe glaucoma patients experienced sustained reductions in IOP and medication use through three years postoperative."
|
PM | Hot Stocks07:14 EDT Philip Morris reports provisional expense of $1.6B related to U.S. tax reform - The company said: "In December 2017, the Tax Cuts and Jobs Act was signed into law. The principal elements of the Act relevant to our consolidated financial statements for the year ended December 31, 2017, were: A reduction of the U.S. federal corporate tax rate from 35% to 21%; and The requirement to pay a one-time transition tax on accumulated foreign earnings, including 2017 earnings. In connection with these elements of the Act, PMI recognized a provisional expense of $1.6B, which was included as a component of income tax expense as follows: A provisional charge of $1.4B, which represents the transition tax of $2.2B, net of a reversal of $0.7B of previously recorded deferred tax liabilities on part of the accumulated foreign earnings, and other items of $0.1B; and Re-measurement of U.S. deferred tax assets and liabilities using a rate of 21%, which, under the Act, is expected to be in place when such deferred assets and liabilities reverse in the future. In connection with this re-measurement, we recorded a provisional charge of $0.2B. While the impacts of the Act reduced net earnings by $1.6B, there was no net impact on operating cash flows for the year, as the changes in deferred taxes and income taxes payable offset the net earnings impact. At December 31, 2017, PMI recorded an income tax payable of $1.7B representing the transition tax of $2.2B, primarily offset by foreign tax credits related to foreign withholding taxes previously paid of $0.5B. The income tax payable is due over an 8-year period beginning in 2018. Other provisions of the Act did not have a significant impact on PMI's consolidated financial statements for the year ended December 31, 2017, but may impact the effective tax rate in subsequent periods."
|
TGT | Hot Stocks07:11 EDT Target, Shipt launch same-day delivery across Southwest - Shipt, a leading online grocery marketplace, and Target Corporation (NYSE:TGT) today announced they will begin same-day delivery of more than 55,000 groceries, essentials, home, electronics, toys and other products across twelve Southwest cities. Beginning February 15, 2018, Shipt will deliver from Target stores in the following metro areas: Arizona: Phoenix metropolitan area; Oklahoma: Oklahoma City, Tulsa; Texas: Austin, College Station, Corpus Christi, Dallas-Fort Worth metroplex, greater Houston, Killeen, Temple, and greater San Antonio.
|
TWTR | Hot Stocks07:10 EDT Twitter reports Q4 owned-and-operated ad revenue up 7% from year ago - Twitter said: "Q4 was a strong finish to the year with total revenue increasing 2% year-over-year, and owned-and-operated - O&O - advertising revenue increasing 7% year-over-year, reflecting better-than-expected growth across all major products and geographies. Q4 revenue growth was driven by continued strong engagement growth, improved revenue features, improved ROI, and better sales execution. Twitter continues to help our partners be relevant in the moment at scale. We are capitalizing on this unique value proposition with improved execution by our sales and operating teams and continued improvements to our core ad products."
|
CATO | Hot Stocks07:10 EDT Cato Corp. reports January SSS down 6% - The Cato Corporation reported sales for the five weeks ended February 3, 2018 of $54.2 million, a 19% increase from sales of $45.5 million for the four week period ended January 28, 2017. The fiscal year ended February 3, 2018 contains 53 weeks versus 52 weeks in fiscal year ended January 28, 2017 and January 2018 contains five weeks versus four weeks in January 2017. On a comparable five-week basis, total sales decreased 7% and same-store sales for the month decreased 6%. Sales for fiscal fourth quarter ended February 3, 2018 were $211.1 million, a decrease of 3% over sales of $218.2 million for the fourth quarter ended January 28, 2017. On a comparable 14-week basis, total sales for the quarter decreased 8% and comparable store sales decreased 8% from last year. For the year, the Company's sales decreased 11% to $842.1 million from 2017 sales of $947.4 million. On a comparable 53-week basis, total sales for the fiscal year ended February 3, 2018 decreased 12% and comparable store sales decreased 12% from last year.
|
GRUB | Hot Stocks07:06 EDT GrubHub provides Q4 key business metrics - Active Diners were 14.5 million, a 77% year-over-year increase from 8.2 million Active Diners in the fourth quarter of 2016. Daily Average Grubs were 392,500, a 34% year-over-year increase from 292,500 DAGs in the fourth quarter of 2016. Gross Food Sales were $1.1 billion, a 39% year-over-year increase from $818 million in the fourth quarter of 2016.
|
TWTR | Hot Stocks07:06 EDT Twitter rises 10% to $29.70 in pre-market after earnings report
|
TEVA | Hot Stocks07:05 EDT Teva reports Q4 generic medicines revenue $3.1B, down 16% y/y - Generic revenues consisted of: U.S. revenues of $1.2 billion, a decrease of 15% compared to the fourth quarter of 2016, mainly due to challenging market dynamics including pricing declines resulting from customer consolidation into large buying groups and accelerated FDA approvals for additional generic versions of competing off-patent medicines, partially offset by new product launches. European revenues of $1.1 billion, flat compared to the fourth quarter of 2016, or a decrease of 8% in local currency terms, compared to the fourth quarter of 2016, mainly due to the exclusion of revenues of Actavis U.K., which was divested in January 2017. Specialty medicines revenues in the fourth quarter of 2017 were $1.8 billion, down 19% compared to the fourth quarter of 2016. Global revenues of COPAXONE were $821 million in the fourth quarter of 2017, a decrease of 19% compared to the fourth quarter of 2016. Global AZILECT revenues were $40 million, a decrease of 55% compared to the fourth quarter of 2016 following the introduction of generic competition to AZILECT in the United States in 2017.
|
CAH | Hot Stocks07:04 EDT Cardinal Health CEO sees FY18 operating performance 'as expected' - "Overall, we are very pleased with the quarter," said Mike Kaufmann, CEO of Cardinal Health. "Our Pharmaceutical Distribution business performed better than expected, and we continue to see strong growth in Specialty Solutions. In the Medical segment, the integration of the Patient Recovery business is progressing as planned, and we are excited by the opportunities in that business. In addition, we remain encouraged by how well our value proposition is resonating with customers. "As we look to the remainder of the year," Kaufmann continued, "we anticipate our overall operating performance to be as expected."
|
YUM | Hot Stocks07:04 EDT Yum! Brands reports Q4 worldwide SSS up 2% - Yum! Brands reports Q4 KFC SSS up 3%, Pizza Hut SSS up 1%, Taco Bell SSS up 2%. In Q4, opened 730 net new units for 3% net unit growth.
|
CVS | Hot Stocks07:02 EDT CVS Health updates adj. consolidated operating profit view to down 1.5%-up 1.5% - CVS Health CEO Larry Merlo stated, "We enter 2018 with the foundation to propel us to win across all of our businesses. I'm very pleased with the strong PBM selling season we had, with gross client wins of $6.2 billion, and our retail collaborations are expected to drive solid performance in our pharmacies. I'm also pleased with the progress we've made in providing superior value for patients, payors, and providers, and we look forward to the opportunities ahead to improve upon our progress." The Company revised its 2018 guidance to reflect the effects of the tax reform achieved through the TCJA. In addition to debt reduction, the Company is dedicating a portion of the benefits to additional investments in employees, data analytics, care management solutions, and service offering enhancements, a portion of which will be capitalized. The impact to the Company's 2018 consolidated operating profit is expected to be at least $275 million. Executive Vice President and CFO David Denton stated, "With $1.2 billion in cash benefits from the Tax Cuts and Jobs Act, we will be able to make strategic investments in our business in 2018 to stimulate greater growth over the longer term, and our updated guidance reflects this. These investments will accelerate our ability to continue to improve health outcomes and lower costs for patients. Additionally, we will spend at least half of the benefits on debt reduction as we look to lower our leverage ratio." As a result of these investments, the Company's previous adjusted consolidated operating profit growth guidance of 1.0% to 4.0% for the full-year 2018 has been updated to down 1.5% to up 1.5%. The Company expects to deliver adjusted consolidated operating profit growth of 0.5% to 4.5% for the first quarter of 2018.
|
TWTR | Hot Stocks07:02 EDT Twitter sees FY18 capital expenditures of $375M-$450M - Sees FY18 stock-based compensation expense to be in the range of $350M-$450M.
|
CAH | Hot Stocks07:02 EDT Cardinal Health board approves new $1B share repurchase authorization
|
CAH | Hot Stocks07:01 EDT Cardinal Health raises FY18 outlook to reflect tax reform
|
TWTR | Hot Stocks07:01 EDT Twitter sees Q1 adjusted EBITDA of $185M-$205M - Sees Q1 adjusted EBITDA margin to be between 33% and 34% and stock-based compensation expense to be in the range of $100M-$110M.
|
TWTR | Hot Stocks07:00 EDT Twitter reports MAUs up 4% from prior year to 330M - Average monthly active usage was 330M for Q4, an increase of 4% year-over-year and flat compared to the previous quarter. As expected, MAU was impacted by seasonality and the change to Safari's third-party app integration, which affected approximately 2 million MAU in Q4, or roughly 1 million in the US and 1 million in international markets, as well as increased information quality efforts, which are overall efforts to reduce malicious activity on the service, inclusive of spam, malicious automation, and fake accounts. Average US MAUs were 68M for Q4, an increase of 2% year-over-year and a decrease of 1 million quarter-over-quarter, reflecting the impact of the change to Safari's third-party app integration, as well as seasonality and increased information quality efforts. Average international MAUs were 262M for Q4, an increase of 4% year-over-year and compared to 261 million in the previous quarter. Daily active usage, or DAU, grew 12% year-over-year, marking our fifth consecutive quarter of double-digit year-over-year growth.
|
CVS | Hot Stocks06:59 EDT CVS Health reports Q4 SSS up 0.1% - Same store sales increased 0.1% and pharmacy same store sales increased 0.4% in the three months ended December 31, 2017. For the year ended December 31, 2017, both same store sales and pharmacy same store sales decreased 2.6%. Pharmacy same stores sales were negatively impacted by approximately 340 and 390 basis points due to recent generic introductions in the three months and year ended December 31, 2017, respectively. Front store same store sales declined 0.7% in the three months ended December 31, 2017, and were positively impacted 80 basis points by seasonal cough and cold. Front store same store sales were negatively impacted by softer customer traffic and efforts to rationalize promotional strategies, partially offset by an increase in basket size. For the year ended December 31, 2017, front store same store sales declined 2.6%. For the three months ended December 31, 2017, the generic dispensing rate increased approximately 80 basis points to 86.9% in our Pharmacy Services Segment and increased approximately 160 basis points to 86.8% in our Retail/LTC Segment, compared to the same quarter in the prior year.
|
MDGL | Hot Stocks06:55 EDT Madrigal Pharmaceuticals' MGL-3196 achieves primary endpoint in trial - Madrigal Pharmaceuticals announced positive results from a double-blind, placebo-controlled, multi-center, 12-week Phase 2 clinical trial in patients with heterozygous familial hypercholesterolemia, a severe genetic dyslipidemia that causes early onset cardiovascular disease. MGL-3196 is a first-in-class, oral, once-daily, liver-directed, thyroid hormone receptor beta-selective agonist medication. MGL-3196 is also being developed as a treatment for patients with non-alcoholic steatohepatitis. In this Phase 2 HeFH trial, 116 patients who were not at their LDL-C goal were randomized in a 2:1 ratio to receive either MGL-3196 or placebo, in addition to their current cholesterol lowering regimen, which included approximately 75% taking high intensity statins (20/40 mg rosuvastatin or 80 mg atorvastatin), and about 2/3 of patients also taking ezetimibe. MGL-3196 treated patients (placebo corrected) achieved highly significant (pless than 0.0001) LDL-C lowering of 18.8%, and 21% LDL-C lowering in those on an optimal dose of MGL-3196. LDL-C lowering was 28.5% in MGL-3196 treated compared to placebo in a prespecified group of patients who did not tolerate high intensity statin doses. Highly significant (pless than0.0001) and numerically similar results were observed with ApoB. Highly significant (pless than0.0001) triglyceride (TG) (25-31%), apolipoprotein CIII (Apo CIII) and Lp(a) lowering (25-40%) were observed in all MGL-3196 treated patients and prespecified subgroups, irrespective of statin treatment. Full results from the Phase 2 trial will be submitted to a future medical conference and for publication. MGL-3196 was well-tolerated with primarily mild and some moderate AEs, the numbers of which were balanced between placebo and drug-treatment groups. Fewer than 7% of patients did not complete the study, and patients who discontinued for AEs, all mild to moderate, were balanced between drug-treated and placebo patients. There were 2 serious adverse events in the study, both unrelated to treatment, one in a placebo and one in a drug-treated patient.
|
NS NSH | Hot Stocks06:54 EDT NuStar Energy, NuStar GP Holdings expect to reset quarterly distribution to 60c - In anticipation of the merger between NuStar Energy (NS) and NuStar GP Holdings (NSH), the partnership announced that management anticipated recommending to board of directors, and the board of directors expects to adopt, a reset of its quarterly distribution per common unit to 60c, or $2.40 on an annualized basis, starting with the Q1 distribution payable in May 2018. After giving effect to the issuance of partnership common units in connection with the merger, this distribution reset is anticipated to reduce annual distribution outflow by approximately $200M per year.
|
BKE | Hot Stocks06:53 EDT The Buckle reports January net sales $55.7M, SSS up 0.2% - The Buckle announced that comparable store net sales, for stores open at least one year, for the 5-week period ended February 3, 2018 increased 0.2 percent from comparable store net sales for the 5-week period ended February 4, 2017. Net sales for the 5-week fiscal month ended February 3, 2018 increased 27.1 percent to $55.7 million from net sales of $43.9 million for the prior year 4-week fiscal month ended January 28, 2017. January 2018 was a 5-week fiscal period, ending Buckle's 53-week fiscal year. The prior January was a 4-week fiscal period, ending a 52-week fiscal year. Comparable store net sales for the month, quarter, and year-to-date periods are compared to the 5-week, 14-week, and 53-week periods ended February 4, 2017. Comparable store net sales for the 14-week fourth quarter ended February 3, 2018 decreased 3.2 percent from comparable store net sales for the 14-week period ended February 4, 2017. Net sales for the 14-week fiscal fourth quarter ended February 3, 2018 increased 0.4 percent to $281.2 million compared to net sales of $280.0 million for the prior year 13-week fiscal fourth quarter ended January 28, 2017. Comparable store net sales year-to-date for the 53-week period ended February 3, 2018 decreased 7.2 percent from comparable store net sales for the 53-week period ended February 4, 2017. Net sales for the 53-week fiscal year ended February 3, 2018 decreased 6.3 percent to $913.4 million from net sales of $974.9 million for the prior year 52-week fiscal year ended January 28, 2017.
|
NS NSH | Hot Stocks06:52 EDT NuStar Energy and NuStar GP Holdings announce merger agreement - NuStar Energy (NS) and NuStar GP Holdings (NSH) announced a definitive agreement that would result in the merger of NSH with a wholly owned subsidiary of the partnership through a unit-for-unit exchange. The merger would result in NSH becoming a wholly owned subsidiary of the partnership and the cancellation of the 2% economic general partner interest in the partnership, the incentive distribution rights in the Partnership and approximately 10.2M partnership common units currently owned by NSH and its subsidiaries. Under the terms of the definitive agreement, NSH unitholders would receive 0.55 of a partnership common unit in exchange for each NSH unit they own at closing, representing a premium of approximately 1.7% based on the closing prices of the partnership's common units and of NSH's units on February 7. The transaction would result in approximately 23.6M additional common units being issued by the partnership. In connection with this transaction, William Greehey, the Chairman of the Board of both NSH and the [partnership, who controls approximately 21% of the outstanding NSH units, has executed a support agreement pursuant to which he has agreed to vote the NSH units controlled by him in favor of the merger. The completion of the merger is subject to the approval of holders of at least a majority of the outstanding NSH units and other closing conditions, and is expected to occur during Q2.
|
YUM GRUB | Hot Stocks06:51 EDT Yum! Brands, GrubHub announce new U.S. Growth partnership - Yum! Brands (YUM) and Grubhub (GRUB) announced a new partnership to drive incremental sales to KFC and Taco Bell restaurants in the U.S. through online ordering for pickup and delivery. YUM also entered into an agreement with Grubhub to purchase $200M of common stock, subject to customary closing conditions, an investment that will provide Grubhub with additional liquidity to accelerate expansion of its industry-leading U.S. delivery network, drive more orders to YUM restaurants, and further enhance the ordering and delivery experience for diners, restaurants and drivers. The unique partnership aligns with YUM's long-term strategies to make its iconic brands easier for consumers to access and drive profitable incremental sales growth for franchisees. Grubhub will be YUM's only national partner providing dedicated support for KFC and Taco Bell branded online delivery channels, along with access to Grubhub's online ordering platform, logistics and last-mile support for delivery orders, and point-of-sale integration to streamline operations. KFC, Taco Bell and Grubhub will engage in joint marketing initiatives that will generate new diners and drive order frequency for existing dinersFinally, as a part of the partnership, Grubhub will expand its board of directors from nine to 10 members and appoint Pizza Hut U.S. President Artie Starrs to the newly created board seat as an independent director. Pizza Hut, which serves and delivers more pizza than any other pizza company in the world, fulfills more than 100 million delivery transactions in the U.S. annually and manages a world-class network of drivers. Grubhub and Pizza Hut will work together to determine how best to leverage their respective scale and expertise. .
|
GOOS | Hot Stocks06:47 EDT Canada Goose appoints Jonathan Sinclair as CFO - Canada Goose announced that Jonathan Sinclair will succeed John Black as CFO and Executive VP and is expected to join the company toward the middle of the year. John has informed the company of his intention to retire and will continue as CFO until Jonathan's appointment, and will remain in a senior role until the end of year to ensure a smooth transition. Sinclair currently serves as CFO of Business Operations at Jimmy Choo.
|
SBH | Hot Stocks06:47 EDT Sally Beauty reports Q1 SSS down 2.2% - The hurricanes that disrupted operations in the fourth quarter of fiscal 2017 continued to have a lingering effect on business in Puerto Rico, particularly in the first half of the fiscal quarter. The negative impact of the hurricanes on both sales growth and same store sales growth was approximately 40 basis points.
|
SBH | Hot Stocks06:46 EDT Sally Beauty sees FY18 SSS approximately flat - For fiscal year 2018, the Company is maintaining its guidance of full year consolidated same store sales to be approximately flat, with more challenging comparisons in the first half of the fiscal year than the second half of the fiscal year. With the addition of new stores from the H. Chalut Ltee acquisition, the Company now expects consolidated year-end store count to increase slightly compared to the prior year. The Company now expects full year gross margin to be approximately flat compared to the prior year. Full year selling, general and administrative expenses (including depreciation and amortization expense) are now expected to be approximately 37.5% of sales versus 37.2% of sales in the prior year. Due to the benefits of U.S. Tax Reform, the Company's expects the consolidated effective tax rate for fiscal 2018 to be in the range of 22% to 24%, including the net benefit from the revaluation of deferred income taxes and the repatriation tax described above. At this time, the Company expects a significant portion of the benefits from U.S. Tax Reform will flow through directly to net earnings as the Company is still evaluating potential investment opportunities afforded by U.S. Tax Reform. In addition, the Company expects incremental cash flow which will allow for the continued strategy of returning capital to shareholders while maintaining appropriate leverage. Full year reported operating earnings are still expected to increase slightly, due primarily to lower restructuring costs in fiscal year 2018. Full year adjusted operating earnings, including the impact of the hurricanes in both years and the strategic investments to drive future growth, are still expected to decline slightly. However, the Company expects full year benefits from its debt refinancing, lower average share count and the benefits of U.S. Tax Reform to result in strong double digit growth in both full year reported and adjusted diluted earnings per share.
|
CDXC | Hot Stocks06:44 EDT ChromaDex's Niagen shows positive results in Alzheimer's - ChromaDex announced results from its collaborative research agreement with the NIA and NIH which appear in the Feb. 5 issue of Proceedings of the National Academy of Sciences showing that Niagen nicotinamide riboside prevented neurological damage and improved cognitive and physical function in a new mouse model of Alzheimer's disease that more closely resembles human AD than other mouse models. These findings arrive a few months after results demonstrating that AD mice treated with NR had lower levels of amyloid deposits, improved mitochondrial energy production and improved memory in his paper, in the journal Nature. Researchers found that the mice receiving Niagen had reduced tangles in their brains, higher neuroplasticity, less DNA damage, increased production of new neurons from neuronal stem cells, and lower levels of neuronal damage and death. In fact, in the area of the brain which typically becomes damaged in individuals with dementia, Niagen appeared to either clear existing DNA damage or prevent it from spreading. The study suggests that NR enters the brain and boosts cellular NAD+ levels when administered orally. The research team attributes the observed physical and cognitive benefits to the rejuvenating effect NR had on stem cells in both muscle and brain tissue.
|
SPB | Hot Stocks06:35 EDT Spectrum Brands sees FY18 CapEx $110M-$120M
|
SPB | Hot Stocks06:35 EDT Spectrum Brands sees FY18 net sales to grow 'above category rates' - FY18 revenue consensus $3.16B. Spectrum Brands expects fiscal 2018 reported net sales from continuing operations to grow above category rates for most categories, along with an anticipated modest positive impact from foreign exchange based upon current rates.
|
SPB | Hot Stocks06:34 EDT Spectrum Brands backs FY18 adjusted free cash flow view $620M-$640M - "Accordingly, we expect stronger performances in our continuing operations in the out quarters and reaffirm our fiscal 2018 adjusted free cash flow guidance of a record $620-$640 million which includes our discontinued operations."
|
SNA | Hot Stocks06:32 EDT Snap-On sees 2018 CapEx $90M-$100M - Anticipates 2018 effective income tax rate 24%-25% vs. a reported and adjusted tax rate in 2017 of 31.1% and 30.6%, respectively.
|
TMUS | Hot Stocks06:17 EDT T-Mobile says adoption of new accounting standard to negatively impact FY18 ARPU - The company sates: "Under existing revenue accounting standards, T-Mobile continues to expect that branded postpaid phone ARPU in full-year 2018 will be generally stable compared to full-year 2017, with some quarterly variations. The adoption of the new revenue accounting standard will impact the timing, amount and allocation of our revenue and is expected to impact ARPU."
|
TMUS | Hot Stocks06:13 EDT T-Mobile reports Q4 total net additions 1.9M - Reports Q4 1.1 million total branded postpaid net additions. Reports Q4 891,000 branded postpaid phone net additions. Reports Q4 149,000 branded prepaid net additions. Reports Q4 1.18% postpaid phone churn. Reports Q4 Free Cash Flow up 53.0% to $1.1 billion.
|
KBR | Hot Stocks06:10 EDT KBR awarded LBED, proprietary equipment supply contract by CDNM in China - KBR announced it has been awarded both a license and engineering, or LBED, and a proprietary equipment supply contract by Cangzhou Dahua New Materials, or CDNM, to build a new polycarbonate plant in Cangzhou City, China. Under the terms of the two contracts, KBR will provide its proprietary PCMAX(TM) technology, basic engineering design package and proprietary equipment supply for a 100,000 metric tonnes per annum single train plant in Cangzhou. CDNM intends to expand annual production at a later stage to 200,000 metric tonnes. The plant will utilize KBR's phosgene-based interfacial polycarbonate PCMAX technology. KBR's unique PCMAX technology offers a wide range of high quality product grades with minimal capital investment.
|
VRTU | Hot Stocks06:07 EDT Virtusa sees Q4 restructuring charge of $0.3M - Virtusa anticipates incurring a restructuring charge of $0.3M in the fourth quarter of fiscal year 2018 as it completes its previously announced resource optimization initiatives, which began in the second quarter of fiscal year 2018. This charge is reflected in the GAAP EPS guidance, and not included in the non-GAAP EPS guidance.
|
DNKN | Hot Stocks06:07 EDT Dunkin' Brands sees low to mid single digit percent revenue growth for 2020 - 2020 guidance includes: Low-single digit percent Dunkin' Donuts U.S. comparable store sales growth accelerating to upwards of 3 percent by 2020. Addition of approximately 1,000 net new Dunkin' Donuts locations in the U.S. by end of 2020, with more than 90 percent of net openings built in markets outside of the Northeast. 75 percent of traditional restaurants expected to be drive-thru locations. Targeting 500-plus DD Green Achievement certified restaurants. Approximately 1,000 NextGen restaurants per year, inclusive of new and remodeled stores, once the new image is released. High-single digit percent growth of Other Revenue driven by consumer packaged goods. Low-single digit percent Baskin-Robbins comparable store sales growth. Zero to 10 net new Baskin-Robbins locations each year. Low to mid-single digit percent revenue growth. Mid to high-single digit percent operating income and adjusted operating income growth.
|
GRA | Hot Stocks06:06 EDT W.R. Grace increases annual dividend 14% to 96c per share - W.R. Grace approved a 14% increase in the company's regular annual cash dividend rate from 84c to 96c per common share. The increase will be effective with the 24c per common share dividend payable March 22 to shareholders of record at the close of business on March 1.
|
DNKN | Hot Stocks06:05 EDT Dunkin' Brands plans to grow revenue low to mid single digits over three years - Dunkin' Brands Group will host its 2018 Investor & Analyst Day today and present its three-year strategic plan to grow revenue by low-to-mid single digit percentages and operating income by mid-to-high single digit percentages. The Company intends to achieve these targets by positioning its core Dunkin' Donuts U.S. brand to compete even more effectively in the coffee and beverage segment, driving profitable sales growth, and further expanding westward across the country. Dunkin' Brands announced plans to add approximately 1,000 net new Dunkin' Donuts locations in the U.S. by the end of 2020 and expects that more than 90 percent will be built outside of the Northeast. Lastly, the Company reaffirmed its intention to eventually have more than 18,000 Dunkin' Donuts restaurants in the U.S. The Company is focused on maintaining and increasing Dunkin' Donuts U.S.' share of the morning daypart before 11 a.m., which accounts for approximately 60 percent of its systemwide sales, as well as unlocking afternoon growth opportunities through menu innovation and national value offers. Dunkin' Donuts is focusing its innovation efforts on beverage items, including a continued focus on Cold Brew, Iced Coffee and Frozen Dunkin' Coffee, which resulted in its highest quarterly beverage comparable sales of the year in the fourth quarter of 2017. The Company also plans to extend its premium tea and frozen beverage lines and introduce more espresso products. Dunkin' Donuts is continuing to evolve its mobile ordering platform by optimizing speed in drive-thru locations. With an estimated 30 percent of crew member time spent taking orders, Dunkin' Donuts expects On-the-Go Mobile Ordering will not only improve order accuracy and speed-of-service, but will also free up crew members' time, enabling them to focus on other operational aspects, including store appearance.
|
SNY | Hot Stocks06:00 EDT Sanofi commences tender offer for acquisition of Bioverativ - Sanofi announced that on February 7, 2018 it commenced a tender offer to acquire all of the outstanding shares of common stock of Bioverativ, for $105 per share in cash, without interest thereon and net of any required tax withholding. The Offer is being made pursuant to the Agreement and Plan of Merger, dated as of January 21, 2018, by and among Bioverativ, Sanofi and Blink Acquisition Corp., a Delaware corporation and an indirect, wholly-owned subsidiary of Sanofi.
|
BMS | Hot Stocks05:59 EDT Bemis raises quarterly dividend to 31c per share from 30c per share - Bemis announced that its board has approved a 3.3% increase in the quarterly cash dividend, increasing it to 31c per share compared to the previous quarterly dividend of 30c per share. The cash dividend is payable on March 1, 2018, to shareholders of record at the close of business on February 20, 2018.
|
STO ACN | Hot Stocks05:43 EDT Statoil, Accenture sign three-year master service agreement - Statoil ASA (STO) and Accenture (ACN) have signed a three-year master service agreement for Accenture to accelerate the delivery of Statoil's global digitalization initiative. Under the terms of the agreement, Accenture will work closely with Statoil to help the company realize its ambitions to implement its recently defined digital roadmap for operations across six key programs: digital safety, security and sustainability; subsurface analytics; next-generation well delivery; the field of the future; data-driven operations; and process digitalization and insight. Specifically, through its Applied Intelligence business, Accenture will provide Statoil with global end-to-end support in data science; robotic process automation, artificial intelligence and cognitive computing; and design thinking and innovation. This will involve the application of key enabling technologies and services, including advanced analytics, as well as robotics, remotely controlled solutions and digital work processes. Accenture's work for Statoil will be coordinated by Statoil's Digital Center of Excellence, which manages digitalization efforts across the company. Accenture will deliver the services to Statoil's locations in Norway, North America and other markets leveraging its Global Delivery Network.
|
NVS | Hot Stocks05:41 EDT Novartis receives FDA approval for Cosentyx label update - Novartis announced that the FDA has approved a label update for Cosentyx the first interleukin-17A inhibitor approved to treat moderate-to-severe plaque psoriasis. The updated label includes Cosentyx data in moderate-to-severe scalp psoriasis - one of the difficult-to-treat forms of the disease, which affects approximately half of all psoriasis patients.The label update is effective in the US immediately, and is based on the proven efficacy and consistent safety profile of Cosentyx from a dedicated Phase III scalp psoriasis trial. The updated label for Cosentyx in scalp psoriasis addresses an important unmet need. Scalp psoriasis can be challenging to treat with topical agents or phototherapy due to the presence of hair and other factors. Approximately half of all 125 million patients with psoriasis suffer from scalp psoriasis.
|
CTRP | Hot Stocks05:39 EDT Ctrip enters partnership with Korail - Ctrip has partnered with South Korea's national rail operator Korail to provide the sales of Korean rail tickets making it easy for member to purchase Korean rail tickets in their local languages. The service will first be available on Trip.com, Ctrip's Asia Pacific focused one-stop travel booking service available in 13 languages and further expand to other platforms within the Ctrip Group. This cooperation marks the first time Korail has partnered with an online third party to sell rail tickets.
|
AMZN | Hot Stocks05:38 EDT Amazon begins grocery delivery from Whole Foods with plans for expansion in 2018 - Amazon and Whole Foods Market today announced the introduction of free two-hour delivery of natural and organic products from Whole Foods Market through Prime Now, with plans to expand across the U.S. in 2018. Starting today, Prime customers in neighborhoods of Austin, Cincinnati, Dallas and Virginia Beach can shop through Prime Now for bestselling items including fresh produce, high quality meat and seafood, everyday staples and other locally sourced items from Whole Foods Market. Customers can start shopping from Whole Foods Market selection at www.primenow.com or by using the Prime Now app available on Android and iOS devices. Prime customers can shop thousands of items across fresh and organic produce, bakery, dairy, meat and seafood, floral and everyday staples from Whole Foods Market available for free two-hour delivery. Select alcohol is also available for delivery to customers. Prime members receive two-hour delivery for free and ultra-fast delivery within one hour for $7.99 on orders of $35 or more. Delivery from Whole Foods Market through Prime Now is available daily from 8 a.m. to 10 p.m.
|
OSK | Hot Stocks05:35 EDT Oshkosh awarded contract for FMTV A2 variant by U.S. Army - Oshkosh Defense, an Oshkosh company, announced that U.S. Army Tank-automotive and Armaments Command, or TACOM, Life Cycle Management Command, or LCMC, has awarded Oshkosh Defense a firm fixed price requirements contract spanning up to seven ordering years for the Family of Medium Tactical Vehicles, or FMTV, A2 variant. The initial estimated contract value is $476 million with no cap on the number of vehicles the Army may purchase.
|
COST | Hot Stocks05:34 EDT Costco reports January SSS up 6% - Reports January net sales up 8.4% to $12.24B. Reports January SSS, excluding the impacts from changes in gasoline prices and foreign exchange, up 2.9%.
|